| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | protein kinase A binding | 1.44e-05 | 58 | 182 | 6 | GO:0051018 | |
| GeneOntologyMolecularFunction | extracellular matrix structural constituent | 5.86e-05 | 188 | 182 | 9 | GO:0005201 | |
| GeneOntologyMolecularFunction | ATPase-coupled transmembrane transporter activity | 6.34e-05 | 109 | 182 | 7 | GO:0042626 | |
| GeneOntologyMolecularFunction | ATPase-coupled monoatomic cation transmembrane transporter activity | 2.53e-04 | 62 | 182 | 5 | GO:0019829 | |
| GeneOntologyMolecularFunction | P-type transmembrane transporter activity | 3.13e-04 | 36 | 182 | 4 | GO:0140358 | |
| GeneOntologyMolecularFunction | P-type ion transporter activity | 3.13e-04 | 36 | 182 | 4 | GO:0015662 | |
| GeneOntologyMolecularFunction | RNA polymerase II-specific DNA-binding transcription factor binding | HDAC9 NCOA6 PSMA6 DMAP1 RNF14 NCOR1 NCOR2 PPARGC1B GTF2I TAF4B SPEN MED13 | 4.61e-04 | 417 | 182 | 12 | GO:0061629 |
| GeneOntologyMolecularFunction | RNA polymerase I core binding | 4.90e-04 | 4 | 182 | 2 | GO:0001042 | |
| GeneOntologyMolecularFunction | phosphatase binding | 7.30e-04 | 264 | 182 | 9 | GO:0019902 | |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | KIF13B ABCA1 ATP13A1 RNF213 ATP10B ABCG4 ATP2C1 ABCC8 MACF1 ATP2A1 DNAH8 ATP4A | 7.53e-04 | 441 | 182 | 12 | GO:0016887 |
| GeneOntologyMolecularFunction | histone H3K36 trimethyltransferase activity | 8.11e-04 | 5 | 182 | 2 | GO:0140955 | |
| GeneOntologyMolecularFunction | DNA-binding transcription factor binding | HDAC9 NCOA6 PSMA6 GRHL2 DMAP1 RNF14 NCOR1 NCOR2 PPARGC1B GTF2I KLF1 TAF4B SPEN MED13 | 9.28e-04 | 582 | 182 | 14 | GO:0140297 |
| GeneOntologyMolecularFunction | ABC-type transporter activity | 1.03e-03 | 49 | 182 | 4 | GO:0140359 | |
| GeneOntologyMolecularFunction | cytoskeletal protein binding | GPHN KIF13B CACNA1C FLNC PHACTR2 ANK2 GIT1 PSG1 MAP2 PSG3 GABARAPL2 EPB41L3 CLSTN1 CLIP1 SETD2 ALMS1 SVIL PAK1 KIRREL1 MACF1 DLEC1 | 1.08e-03 | 1099 | 182 | 21 | GO:0008092 |
| GeneOntologyMolecularFunction | nuclear retinoid X receptor binding | 1.15e-03 | 23 | 182 | 3 | GO:0046965 | |
| GeneOntologyMolecularFunction | histone acetyltransferase activity | 1.19e-03 | 51 | 182 | 4 | GO:0004402 | |
| GeneOntologyMolecularFunction | pyruvate dehydrogenase (NAD+) activity | 1.21e-03 | 6 | 182 | 2 | GO:0034604 | |
| GeneOntologyMolecularFunction | pyruvate dehydrogenase [NAD(P)+] activity | 1.21e-03 | 6 | 182 | 2 | GO:0034603 | |
| GeneOntologyMolecularFunction | pyruvate dehydrogenase activity | 1.21e-03 | 6 | 182 | 2 | GO:0004738 | |
| GeneOntologyMolecularFunction | primary active transmembrane transporter activity | 1.26e-03 | 178 | 182 | 7 | GO:0015399 | |
| GeneOntologyMolecularFunction | structural molecule activity | MXRA5 ANK2 MYOM1 COL6A6 GIT1 MAP2 TNC EPB41L3 HMCN2 HMCN1 MUC17 ACAN AHNAK VCAN MACF1 MYOM2 CRYBG3 TNXB | 1.34e-03 | 891 | 182 | 18 | GO:0005198 |
| GeneOntologyMolecularFunction | ATP-dependent activity | KIF13B ABCA1 ATP13A1 RNF213 ATP10B ABCG4 ATP2C1 ABCC8 MACF1 ACSM5 ATP2A1 DNAH8 ATP4A ACSL5 | 1.54e-03 | 614 | 182 | 14 | GO:0140657 |
| GeneOntologyMolecularFunction | peptide-lysine-N-acetyltransferase activity | 1.58e-03 | 55 | 182 | 4 | GO:0061733 | |
| GeneOntologyMolecularFunction | transcription coregulator activity | HDAC9 NCOA6 JADE1 DMAP1 RNF14 NCOR1 NCOR2 PPARGC1B SETD5 CAMTA1 KAT6B SPEN MED13 | 1.99e-03 | 562 | 182 | 13 | GO:0003712 |
| GeneOntologyMolecularFunction | peptide N-acetyltransferase activity | 2.19e-03 | 60 | 182 | 4 | GO:0034212 | |
| GeneOntologyBiologicalProcess | cell-cell adhesion via plasma-membrane adhesion molecules | PRTG PSG1 PSG3 ICAM1 PCDH11Y MCAM CDH23 MDGA2 NECTIN3 CLSTN1 FAT2 ATP2C1 HMCN2 HMCN1 PCDH9 CDH13 | 1.96e-08 | 313 | 182 | 16 | GO:0098742 |
| GeneOntologyBiologicalProcess | homophilic cell adhesion via plasma membrane adhesion molecules | PRTG PSG1 PSG3 PCDH11Y CDH23 NECTIN3 CLSTN1 FAT2 HMCN2 HMCN1 PCDH9 CDH13 | 1.08e-07 | 187 | 182 | 12 | GO:0007156 |
| GeneOntologyBiologicalProcess | protein localization to cell periphery | GPHN ANK2 GIT1 SYTL2 PDZK1P1 NBEA NECTIN3 EPB41L3 CLSTN1 BLZF1 CLIP1 DENND4C EFR3A WDR19 GORASP2 ATP2C1 MACF1 | 2.19e-07 | 422 | 182 | 17 | GO:1990778 |
| GeneOntologyBiologicalProcess | cell-cell adhesion | PRTG PSG1 PSG3 ICAM1 PCDH11Y TNFRSF14 MCAM CDH23 MDGA2 NECTIN3 CLSTN1 ITPKB EFR3A FAT2 ATP2C1 HMCN2 HMCN1 BTN2A3P KIRREL1 SIGLEC1 TNR TNXB PCDH9 ALOX5 CDH13 CNTN1 CD276 | 9.23e-07 | 1077 | 182 | 27 | GO:0098609 |
| GeneOntologyBiologicalProcess | actin filament-based process | CACNA1C FLNC PHACTR2 FRMPD4 ANK2 MYOM1 ICAM1 KCNE5 EPB41L3 ARHGEF11 PPARGC1B ATP2C1 CSF1R ALMS1 HMCN1 KCND3 WASHC5 SVIL PAK1 KIRREL1 AKAP13 MYOM2 ATP2A1 TNXB | 1.72e-06 | 912 | 182 | 24 | GO:0030029 |
| GeneOntologyBiologicalProcess | localization within membrane | GPHN ANK2 GIT1 ATP13A1 SYTL2 PDZK1P1 NBEA NECTIN3 EPB41L3 CLSTN1 BLZF1 CLIP1 DENND4C EFR3A WDR19 GORASP2 VPS52 ATP2C1 PAK1 MACF1 OGA CDH13 | 2.29e-06 | 798 | 182 | 22 | GO:0051668 |
| GeneOntologyBiologicalProcess | protein localization to membrane | GPHN ANK2 GIT1 ATP13A1 SYTL2 PDZK1P1 NBEA NECTIN3 EPB41L3 CLSTN1 BLZF1 CLIP1 DENND4C EFR3A WDR19 GORASP2 ATP2C1 PAK1 MACF1 OGA | 4.47e-06 | 705 | 182 | 20 | GO:0072657 |
| GeneOntologyBiologicalProcess | negative regulation of response to wounding | 1.63e-05 | 126 | 182 | 8 | GO:1903035 | |
| GeneOntologyBiologicalProcess | neuroblast migration | 5.46e-05 | 9 | 182 | 3 | GO:0097402 | |
| GeneOntologyBiologicalProcess | actin cytoskeleton organization | FLNC PHACTR2 FRMPD4 MYOM1 ICAM1 EPB41L3 ARHGEF11 PPARGC1B ATP2C1 CSF1R ALMS1 HMCN1 WASHC5 SVIL PAK1 KIRREL1 AKAP13 MYOM2 TNXB | 9.30e-05 | 803 | 182 | 19 | GO:0030036 |
| GeneOntologyBiologicalProcess | inner ear receptor cell stereocilium organization | 1.03e-04 | 53 | 182 | 5 | GO:0060122 | |
| GeneOntologyBiologicalProcess | muscle system process | CACNA1C ANK2 MYOM1 KCNE5 CMYA5 ARHGEF11 RYR3 KCND3 ABCC8 PAK1 AKAP13 MYOM2 OGA ATP2A1 KLK1 | 1.08e-04 | 547 | 182 | 15 | GO:0003012 |
| GeneOntologyBiologicalProcess | cholesterol homeostasis | 1.17e-04 | 124 | 182 | 7 | GO:0042632 | |
| GeneOntologyBiologicalProcess | sterol homeostasis | 1.23e-04 | 125 | 182 | 7 | GO:0055092 | |
| GeneOntologyBiologicalProcess | cell junction organization | GPHN FRMPD4 ANK2 PSG1 PSG3 TNC MDGA2 NBEA NECTIN3 EPB41L3 CLSTN1 GRHL2 CSF1R HMCN2 SETD5 ABCC8 PAK1 KIRREL1 MACF1 TNR CDH13 | 1.45e-04 | 974 | 182 | 21 | GO:0034330 |
| GeneOntologyBiologicalProcess | protein localization to plasma membrane | ANK2 SYTL2 PDZK1P1 NECTIN3 EPB41L3 BLZF1 DENND4C EFR3A GORASP2 ATP2C1 MACF1 | 1.50e-04 | 324 | 182 | 11 | GO:0072659 |
| GeneOntologyBiologicalProcess | neuron projection development | KIF13B IFT27 PRTG GIT1 MAP2 TNC RRN3P2 CDH23 ZSWIM6 EPB41L3 GPRIN1 CLIP1 CSF1R HMCN2 ALMS1 WASHC5 RRN3 VPS13A PAK1 MACF1 STRC TNR TNXB CNTN1 STRCP1 | 1.66e-04 | 1285 | 182 | 25 | GO:0031175 |
| GeneOntologyBiologicalProcess | negative regulation of vascular permeability | 2.21e-04 | 34 | 182 | 4 | GO:0043116 | |
| GeneOntologyBiologicalProcess | negative regulation of wound healing | 2.34e-04 | 98 | 182 | 6 | GO:0061045 | |
| GeneOntologyBiologicalProcess | ventricular cardiac muscle cell action potential | 3.09e-04 | 37 | 182 | 4 | GO:0086005 | |
| GeneOntologyCellularComponent | myofibril | CACNA1C FLNC ANK2 MYOM1 PSMA6 CMYA5 RYR3 AHNAK SPHKAP SVIL PAK1 MYOM2 ATP2A1 | 9.57e-07 | 273 | 184 | 13 | GO:0030016 |
| GeneOntologyCellularComponent | costamere | 1.17e-06 | 22 | 184 | 5 | GO:0043034 | |
| GeneOntologyCellularComponent | perisynaptic extracellular matrix | 1.83e-06 | 11 | 184 | 4 | GO:0098966 | |
| GeneOntologyCellularComponent | contractile muscle fiber | CACNA1C FLNC ANK2 MYOM1 PSMA6 CMYA5 RYR3 AHNAK SPHKAP SVIL PAK1 MYOM2 ATP2A1 | 1.88e-06 | 290 | 184 | 13 | GO:0043292 |
| GeneOntologyCellularComponent | tenascin complex | 2.67e-06 | 4 | 184 | 3 | GO:0090733 | |
| GeneOntologyCellularComponent | synapse-associated extracellular matrix | 3.90e-06 | 13 | 184 | 4 | GO:0099535 | |
| GeneOntologyCellularComponent | collagen-containing extracellular matrix | A2M LAMB4 MXRA5 COL6A6 TNC ICAM1 IGFBPL1 HMCN2 HMCN1 MUC17 ACAN LPA VCAN TNR TNXB KNG1 CDH13 | 4.81e-06 | 530 | 184 | 17 | GO:0062023 |
| GeneOntologyCellularComponent | sarcomere | CACNA1C FLNC ANK2 MYOM1 PSMA6 CMYA5 RYR3 SPHKAP PAK1 MYOM2 ATP2A1 | 1.36e-05 | 249 | 184 | 11 | GO:0030017 |
| GeneOntologyCellularComponent | external encapsulating structure | A2M LAMB4 MXRA5 COL6A6 TNC ICAM1 PKHD1L1 IGFBPL1 HMCN2 HMCN1 MUC17 ACAN LPA VCAN TNR TNXB KNG1 CDH13 | 2.18e-05 | 658 | 184 | 18 | GO:0030312 |
| GeneOntologyCellularComponent | stereocilium tip | 3.75e-05 | 22 | 184 | 4 | GO:0032426 | |
| GeneOntologyCellularComponent | sarcolemma | 4.88e-05 | 190 | 184 | 9 | GO:0042383 | |
| GeneOntologyCellularComponent | extracellular matrix | A2M LAMB4 MXRA5 COL6A6 TNC ICAM1 IGFBPL1 HMCN2 HMCN1 MUC17 ACAN LPA VCAN TNR TNXB KNG1 CDH13 | 7.25e-05 | 656 | 184 | 17 | GO:0031012 |
| GeneOntologyCellularComponent | perineuronal net | 7.69e-05 | 10 | 184 | 3 | GO:0072534 | |
| GeneOntologyCellularComponent | A band | 9.30e-05 | 52 | 184 | 5 | GO:0031672 | |
| GeneOntologyCellularComponent | GABA-ergic synapse | 1.05e-04 | 164 | 184 | 8 | GO:0098982 | |
| GeneOntologyCellularComponent | anchoring junction | FLNC ANK2 GIT1 PSG1 PSG3 TNC ICAM1 MCAM NECTIN3 EPB41L3 GRHL2 AKAP12 FAT2 HMCN1 AHNAK SVIL PAK1 KIRREL1 ANO7 PCDH9 CDH13 | 1.45e-04 | 976 | 184 | 21 | GO:0070161 |
| GeneOntologyCellularComponent | M band | 1.52e-04 | 31 | 184 | 4 | GO:0031430 | |
| GeneOntologyCellularComponent | 9+2 non-motile cilium | 2.27e-04 | 14 | 184 | 3 | GO:0097732 | |
| GeneOntologyCellularComponent | kinocilium | 2.27e-04 | 14 | 184 | 3 | GO:0060091 | |
| GeneOntologyCellularComponent | stereocilium | 3.56e-04 | 69 | 184 | 5 | GO:0032420 | |
| GeneOntologyCellularComponent | cilium | IFT27 PSG1 PSG3 PCDH11Y CDH23 JADE1 LRRC43 WDR19 TXNDC15 ALMS1 VCAN VPS13A CC2D2A DLD DLEC1 STRC DNAH8 STRCP1 BBOF1 | 3.75e-04 | 898 | 184 | 19 | GO:0005929 |
| GeneOntologyCellularComponent | protein complex involved in cell-matrix adhesion | 4.17e-04 | 17 | 184 | 3 | GO:0098637 | |
| GeneOntologyCellularComponent | postsynaptic specialization | GPHN CACNA1C FRMPD4 ANK2 GIT1 MAP2 NECTIN3 PRRT2 EPB41L3 CLSTN1 KCND3 PAK1 MACF1 | 5.35e-04 | 503 | 184 | 13 | GO:0099572 |
| GeneOntologyCellularComponent | stereocilium bundle | 6.66e-04 | 79 | 184 | 5 | GO:0032421 | |
| GeneOntologyCellularComponent | postsynaptic density | GPHN CACNA1C FRMPD4 ANK2 GIT1 MAP2 NECTIN3 PRRT2 EPB41L3 CLSTN1 PAK1 MACF1 | 6.79e-04 | 451 | 184 | 12 | GO:0014069 |
| GeneOntologyCellularComponent | I band | 6.84e-04 | 166 | 184 | 7 | GO:0031674 | |
| GeneOntologyCellularComponent | neuron to neuron synapse | GPHN CACNA1C FRMPD4 ANK2 GIT1 MAP2 NECTIN3 PRRT2 EPB41L3 CLSTN1 PAK1 MACF1 TNR | 7.68e-04 | 523 | 184 | 13 | GO:0098984 |
| GeneOntologyCellularComponent | histone deacetylase complex | 9.29e-04 | 85 | 184 | 5 | GO:0000118 | |
| GeneOntologyCellularComponent | asymmetric synapse | GPHN CACNA1C FRMPD4 ANK2 GIT1 MAP2 NECTIN3 PRRT2 EPB41L3 CLSTN1 PAK1 MACF1 | 1.10e-03 | 477 | 184 | 12 | GO:0032279 |
| GeneOntologyCellularComponent | cell-cell contact zone | 1.46e-03 | 94 | 184 | 5 | GO:0044291 | |
| GeneOntologyCellularComponent | side of membrane | GPHN ABCA1 ANK2 PSG1 PSG3 ICAM1 TNFRSF14 MCAM MUC16 MDGA2 RYR3 MUC17 LPA BTN2A3P CDH13 CNTN1 CD276 | 1.92e-03 | 875 | 184 | 17 | GO:0098552 |
| GeneOntologyCellularComponent | cell surface | CACNA1C ABCA1 PSG1 PSG3 ICAM1 TNFRSF14 MCAM MUC16 CLSTN1 CSF1R MUC17 LPA VCAN BTN2A3P STRC TMX3 TNR CDH13 STRCP1 CD276 | 1.92e-03 | 1111 | 184 | 20 | GO:0009986 |
| GeneOntologyCellularComponent | cell-substrate junction | 1.95e-03 | 443 | 184 | 11 | GO:0030055 | |
| GeneOntologyCellularComponent | pyruvate dehydrogenase complex | 2.08e-03 | 8 | 184 | 2 | GO:0045254 | |
| GeneOntologyCellularComponent | Z disc | 2.23e-03 | 151 | 184 | 6 | GO:0030018 | |
| GeneOntologyCellularComponent | external side of plasma membrane | ABCA1 PSG1 PSG3 ICAM1 TNFRSF14 MCAM MUC16 MUC17 LPA BTN2A3P CDH13 CD276 | 2.23e-03 | 519 | 184 | 12 | GO:0009897 |
| GeneOntologyCellularComponent | cell-cell junction | ANK2 PSG1 PSG3 NECTIN3 EPB41L3 GRHL2 FAT2 HMCN1 AHNAK PAK1 KIRREL1 PCDH9 CDH13 | 2.28e-03 | 591 | 184 | 13 | GO:0005911 |
| GeneOntologyCellularComponent | actin-based cell projection | 3.31e-03 | 278 | 184 | 8 | GO:0098858 | |
| GeneOntologyCellularComponent | supramolecular fiber | KIF13B CACNA1C FLNC SNPH ANK2 MYOM1 MAP2 PSMA6 CMYA5 CLIP1 RYR3 AHNAK SPHKAP SVIL PAK1 MACF1 AKAP13 MYOM2 ATP2A1 DNAH8 | 3.78e-03 | 1179 | 184 | 20 | GO:0099512 |
| GeneOntologyCellularComponent | supramolecular polymer | KIF13B CACNA1C FLNC SNPH ANK2 MYOM1 MAP2 PSMA6 CMYA5 CLIP1 RYR3 AHNAK SPHKAP SVIL PAK1 MACF1 AKAP13 MYOM2 ATP2A1 DNAH8 | 4.07e-03 | 1187 | 184 | 20 | GO:0099081 |
| GeneOntologyCellularComponent | basement membrane | 4.53e-03 | 122 | 184 | 5 | GO:0005604 | |
| MousePheno | lethality throughout fetal growth and development, complete penetrance | NRBP1 CACNA1C NCOA6 L3MBTL2 GRHL2 DENND4C WDR19 LIG1 NCOR1 NCOR2 KLF1 SETD5 SPEN | 4.39e-06 | 263 | 148 | 13 | MP:0011099 |
| MousePheno | prenatal growth retardation | NCOA6 ABCA1 ZFAT L3MBTL2 PDHA1 ACTR5 ATP13A1 RRN3P2 REV3L GRHL2 LIG1 NCOR2 SETD2 ATP2C1 GTF2I SETD5 RRN3 VCAN CC2D2A DLD KIRREL1 PDS5A AKAP13 OGA | 1.37e-05 | 869 | 148 | 24 | MP:0010865 |
| MousePheno | lethality throughout fetal growth and development | NRBP1 CACNA1C NCOA6 ABCA1 L3MBTL2 GRHL2 DENND4C WDR19 LIG1 NCOR1 NCOR2 KLF1 SETD5 VCAN CC2D2A SPEN | 1.49e-05 | 435 | 148 | 16 | MP:0006208 |
| MousePheno | embryonic growth retardation | NCOA6 ABCA1 ZFAT L3MBTL2 PDHA1 ACTR5 ATP13A1 RRN3P2 REV3L GRHL2 LIG1 NCOR2 SETD2 ATP2C1 GTF2I SETD5 RRN3 VCAN DLD KIRREL1 AKAP13 | 5.30e-05 | 763 | 148 | 21 | MP:0003984 |
| Domain | Ig-like_fold | FLNC PRTG MXRA5 MYOM1 VSIG2 PSG1 PSG3 TNC ICAM1 MCAM IL20RA MDGA2 NECTIN3 CMYA5 CCDC141 PKHD1L1 IGFBPL1 CSF1R HMCN2 HMCN1 VCAN BTN2A3P KIRREL1 MYOM2 SIGLEC1 CAMTA1 TNR TNXB LRIT1 CNTN1 CD276 | 1.53e-12 | 706 | 181 | 31 | IPR013783 |
| Domain | - | FLNC PRTG MXRA5 MYOM1 VSIG2 PSG1 PSG3 TNC ICAM1 MCAM IL20RA MDGA2 NECTIN3 CMYA5 CCDC141 PKHD1L1 IGFBPL1 CSF1R HMCN1 VCAN KIRREL1 MYOM2 SIGLEC1 CAMTA1 TNR TNXB LRIT1 CNTN1 CD276 | 9.65e-12 | 663 | 181 | 29 | 2.60.40.10 |
| Domain | IGc2 | PRTG MXRA5 MYOM1 VSIG2 PSG1 PSG3 MCAM MDGA2 IGFBPL1 CSF1R HMCN2 HMCN1 KIRREL1 MYOM2 SIGLEC1 LRIT1 CNTN1 CD276 | 1.50e-11 | 235 | 181 | 18 | SM00408 |
| Domain | Ig_sub2 | PRTG MXRA5 MYOM1 VSIG2 PSG1 PSG3 MCAM MDGA2 IGFBPL1 CSF1R HMCN2 HMCN1 KIRREL1 MYOM2 SIGLEC1 LRIT1 CNTN1 CD276 | 1.50e-11 | 235 | 181 | 18 | IPR003598 |
| Domain | IG_LIKE | PRTG MXRA5 MYOM1 VSIG2 PSG1 PSG3 ICAM1 MCAM MDGA2 NECTIN3 CCDC141 IGFBPL1 CSF1R HMCN2 HMCN1 VCAN BTN2A3P KIRREL1 MYOM2 SIGLEC1 LRIT1 CNTN1 CD276 | 4.40e-10 | 491 | 181 | 23 | PS50835 |
| Domain | Ig-like_dom | PRTG MXRA5 MYOM1 VSIG2 PSG1 PSG3 ICAM1 MCAM MDGA2 NECTIN3 CCDC141 IGFBPL1 CSF1R HMCN2 HMCN1 VCAN BTN2A3P KIRREL1 MYOM2 SIGLEC1 LRIT1 CNTN1 CD276 | 7.03e-10 | 503 | 181 | 23 | IPR007110 |
| Domain | IG | PRTG MXRA5 MYOM1 VSIG2 PSG1 PSG3 ICAM1 MCAM MDGA2 NECTIN3 IGFBPL1 CSF1R HMCN2 HMCN1 VCAN KIRREL1 MYOM2 SIGLEC1 LRIT1 CNTN1 CD276 | 8.68e-10 | 421 | 181 | 21 | SM00409 |
| Domain | Ig_sub | PRTG MXRA5 MYOM1 VSIG2 PSG1 PSG3 ICAM1 MCAM MDGA2 NECTIN3 IGFBPL1 CSF1R HMCN2 HMCN1 VCAN KIRREL1 MYOM2 SIGLEC1 LRIT1 CNTN1 CD276 | 8.68e-10 | 421 | 181 | 21 | IPR003599 |
| Domain | Ig_I-set | PRTG MXRA5 MYOM1 VSIG2 MDGA2 IGFBPL1 HMCN2 HMCN1 KIRREL1 MYOM2 SIGLEC1 LRIT1 CNTN1 | 4.31e-08 | 190 | 181 | 13 | IPR013098 |
| Domain | I-set | PRTG MXRA5 MYOM1 VSIG2 MDGA2 IGFBPL1 HMCN2 HMCN1 KIRREL1 MYOM2 SIGLEC1 LRIT1 CNTN1 | 4.31e-08 | 190 | 181 | 13 | PF07679 |
| Domain | Ig_V-set | VSIG2 PSG1 PSG3 MCAM NECTIN3 CSF1R HMCN1 VCAN BTN2A3P KIRREL1 SIGLEC1 CD276 | 5.67e-07 | 199 | 181 | 12 | IPR013106 |
| Domain | FN3_dom | FLNC PRTG MYOM1 TNC IL20RA MDGA2 CMYA5 MYOM2 TNR TNXB LRIT1 CNTN1 | 9.55e-07 | 209 | 181 | 12 | IPR003961 |
| Domain | V-set | VSIG2 PSG1 PSG3 MCAM NECTIN3 CSF1R VCAN BTN2A3P KIRREL1 SIGLEC1 CD276 | 1.85e-06 | 184 | 181 | 11 | PF07686 |
| Domain | FN3 | PRTG MYOM1 TNC IL20RA MDGA2 CMYA5 MYOM2 TNR TNXB LRIT1 CNTN1 | 3.96e-06 | 199 | 181 | 11 | PS50853 |
| Domain | FN3 | 1.33e-05 | 185 | 181 | 10 | SM00060 | |
| Domain | ig | 1.68e-05 | 190 | 181 | 10 | PF00047 | |
| Domain | Immunoglobulin | 1.68e-05 | 190 | 181 | 10 | IPR013151 | |
| Domain | ATPase_P-typ_P_site | 2.39e-05 | 36 | 181 | 5 | IPR018303 | |
| Domain | P_typ_ATPase | 2.39e-05 | 36 | 181 | 5 | IPR001757 | |
| Domain | ATPASE_E1_E2 | 2.39e-05 | 36 | 181 | 5 | PS00154 | |
| Domain | ATPase_P-typ_transduc_dom_A | 2.74e-05 | 37 | 181 | 5 | IPR008250 | |
| Domain | E1-E2_ATPase | 2.74e-05 | 37 | 181 | 5 | PF00122 | |
| Domain | fn3 | 2.93e-05 | 162 | 181 | 9 | PF00041 | |
| Domain | C2-set_2 | 4.57e-05 | 41 | 181 | 5 | PF08205 | |
| Domain | CD80_C2-set | 4.57e-05 | 41 | 181 | 5 | IPR013162 | |
| Domain | N-CoR_GPS2_interact | 9.34e-05 | 2 | 181 | 2 | IPR031557 | |
| Domain | GPS2_interact | 9.34e-05 | 2 | 181 | 2 | PF15784 | |
| Domain | - | 2.48e-04 | 32 | 181 | 4 | 3.40.1110.10 | |
| Domain | - | 2.48e-04 | 32 | 181 | 4 | 2.70.150.10 | |
| Domain | ATPase_P-typ_cyto_domN | 3.53e-04 | 35 | 181 | 4 | IPR023299 | |
| Domain | ATPase_P-typ_TM_dom | 4.57e-04 | 16 | 181 | 3 | IPR023298 | |
| Domain | - | 4.57e-04 | 16 | 181 | 3 | 1.20.1110.10 | |
| Domain | ATPase_P-typ_cation-transptr_C | 5.51e-04 | 17 | 181 | 3 | IPR006068 | |
| Domain | Cation_ATPase_C | 5.51e-04 | 17 | 181 | 3 | PF00689 | |
| Domain | G2F | 5.53e-04 | 4 | 181 | 2 | PF07474 | |
| Domain | NIDOGEN_G2 | 5.53e-04 | 4 | 181 | 2 | PS50993 | |
| Domain | GFP | 5.53e-04 | 4 | 181 | 2 | IPR009017 | |
| Domain | G2_nidogen/fibulin_G2F | 5.53e-04 | 4 | 181 | 2 | IPR006605 | |
| Domain | Cation_ATPase_N | 6.56e-04 | 18 | 181 | 3 | PF00690 | |
| Domain | Cation_ATPase_N | 6.56e-04 | 18 | 181 | 3 | SM00831 | |
| Domain | ATPase_P-typ_cation-transptr_N | 7.74e-04 | 19 | 181 | 3 | IPR004014 | |
| Domain | CADHERIN_1 | 8.18e-04 | 113 | 181 | 6 | PS00232 | |
| Domain | Cadherin | 8.18e-04 | 113 | 181 | 6 | PF00028 | |
| Domain | CADHERIN_2 | 8.56e-04 | 114 | 181 | 6 | PS50268 | |
| Domain | - | 8.56e-04 | 114 | 181 | 6 | 2.60.40.60 | |
| Domain | EGF_1 | 8.77e-04 | 255 | 181 | 9 | PS00022 | |
| Domain | CA | 8.96e-04 | 115 | 181 | 6 | SM00112 | |
| Domain | Protocadherin | 9.16e-04 | 5 | 181 | 2 | PF08374 | |
| Domain | RII_binding_1 | 9.16e-04 | 5 | 181 | 2 | PF10522 | |
| Domain | DUF4704 | 9.16e-04 | 5 | 181 | 2 | IPR031570 | |
| Domain | RII_binding_1 | 9.16e-04 | 5 | 181 | 2 | IPR018459 | |
| Domain | DUF4704 | 9.16e-04 | 5 | 181 | 2 | PF15787 | |
| Domain | Protocadherin | 9.16e-04 | 5 | 181 | 2 | IPR013585 | |
| Domain | Cadherin-like | 9.38e-04 | 116 | 181 | 6 | IPR015919 | |
| Domain | HAD-like_dom | 1.02e-03 | 79 | 181 | 5 | IPR023214 | |
| Domain | Cadherin | 1.02e-03 | 118 | 181 | 6 | IPR002126 | |
| Domain | EGF-like_CS | 1.03e-03 | 261 | 181 | 9 | IPR013032 | |
| Domain | EGF_2 | 1.15e-03 | 265 | 181 | 9 | PS01186 | |
| Domain | PH_BEACH | 1.37e-03 | 6 | 181 | 2 | PF14844 | |
| Domain | SPOC_C | 1.37e-03 | 6 | 181 | 2 | IPR012921 | |
| Domain | SPOC | 1.37e-03 | 6 | 181 | 2 | PF07744 | |
| Domain | Fibrinogen_a/b/g_C_2 | 1.56e-03 | 24 | 181 | 3 | IPR014715 | |
| Domain | - | 1.56e-03 | 24 | 181 | 3 | 4.10.530.10 | |
| Domain | LEM/LEM-like_dom | 1.90e-03 | 7 | 181 | 2 | IPR011015 | |
| Domain | LEM_dom | 1.90e-03 | 7 | 181 | 2 | IPR003887 | |
| Domain | LEM | 1.90e-03 | 7 | 181 | 2 | PF03020 | |
| Domain | LEM | 1.90e-03 | 7 | 181 | 2 | PS50954 | |
| Domain | - | 1.90e-03 | 7 | 181 | 2 | 1.10.720.40 | |
| Domain | EGF_3 | 2.11e-03 | 235 | 181 | 8 | PS50026 | |
| Domain | Fibrinogen_C | 2.21e-03 | 27 | 181 | 3 | PF00147 | |
| Domain | SANT | 2.45e-03 | 28 | 181 | 3 | PS51293 | |
| Domain | PH-BEACH_dom | 2.52e-03 | 8 | 181 | 2 | IPR023362 | |
| Domain | - | 2.52e-03 | 8 | 181 | 2 | 2.30.29.40 | |
| Domain | PH_BEACH | 2.52e-03 | 8 | 181 | 2 | PS51783 | |
| Domain | FBG | 2.72e-03 | 29 | 181 | 3 | SM00186 | |
| Domain | - | 3.00e-03 | 30 | 181 | 3 | 3.90.215.10 | |
| Domain | Fibrinogen_a/b/g_C_1 | 3.00e-03 | 30 | 181 | 3 | IPR014716 | |
| Domain | EGF-like_dom | 3.02e-03 | 249 | 181 | 8 | IPR000742 | |
| Domain | BEACH | 3.22e-03 | 9 | 181 | 2 | PS50197 | |
| Domain | Beach | 3.22e-03 | 9 | 181 | 2 | PF02138 | |
| Domain | - | 3.22e-03 | 9 | 181 | 2 | 1.10.1540.10 | |
| Domain | Beach | 3.22e-03 | 9 | 181 | 2 | SM01026 | |
| Domain | BEACH_dom | 3.22e-03 | 9 | 181 | 2 | IPR000409 | |
| Domain | - | 3.45e-03 | 150 | 181 | 6 | 2.30.42.10 | |
| Domain | FIBRINOGEN_C_1 | 3.61e-03 | 32 | 181 | 3 | PS00514 | |
| Domain | Fibrinogen_a/b/g_C_dom | 3.61e-03 | 32 | 181 | 3 | IPR002181 | |
| Domain | FIBRINOGEN_C_2 | 3.61e-03 | 32 | 181 | 3 | PS51406 | |
| Domain | PDZ | 3.68e-03 | 152 | 181 | 6 | IPR001478 | |
| Domain | CAP_GLY | 3.99e-03 | 10 | 181 | 2 | PF01302 | |
| Domain | CAP_GLY | 3.99e-03 | 10 | 181 | 2 | SM01052 | |
| Domain | - | 3.99e-03 | 10 | 181 | 2 | 2.30.30.190 | |
| Domain | Hydrolase_3 | 3.99e-03 | 10 | 181 | 2 | PF08282 | |
| Domain | CAP_GLY_1 | 3.99e-03 | 10 | 181 | 2 | PS00845 | |
| Domain | CAP_GLY_2 | 3.99e-03 | 10 | 181 | 2 | PS50245 | |
| Domain | CAP-Gly_domain | 3.99e-03 | 10 | 181 | 2 | IPR000938 | |
| Domain | Cadherin_CS | 4.20e-03 | 109 | 181 | 5 | IPR020894 | |
| Domain | ConA-like_dom | 5.58e-03 | 219 | 181 | 7 | IPR013320 | |
| Domain | GrpE_coiled_coil | 5.78e-03 | 12 | 181 | 2 | IPR013805 | |
| Domain | MYB_LIKE | 5.89e-03 | 38 | 181 | 3 | PS50090 | |
| Domain | IGv | 6.07e-03 | 75 | 181 | 4 | SM00406 | |
| Pathway | REACTOME_ECM_PROTEOGLYCANS | 7.18e-06 | 47 | 142 | 6 | MM14925 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | 1.16e-05 | 258 | 142 | 12 | MM14572 | |
| Pubmed | GPHN NRBP1 DIDO1 EPB41L3 POLR1G ANKLE2 CLIP1 DENND4C DMAP1 LIG1 NCOR1 USP5 GORASP2 GTF2I MKI67 PAK1 ZNF638 AKAP13 SPEN SON | 4.66e-12 | 503 | 187 | 20 | 16964243 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | NCOA6 GIT1 PDHA1 DIDO1 POLR1G GPRIN1 CLIP1 HNRNPF SPICE1 LIG1 NCOR1 NCOR2 SETD2 GTF2I SVIL YLPM1 MKI67 ZNF638 TMPO KAT6B OGA SPEN MED13 SON | 5.84e-12 | 774 | 187 | 24 | 15302935 |
| Pubmed | MCAM MUC16 RNF213 NBEA CEP192 EPB41L3 GPRIN1 PKHD1L1 AKAP12 LIG1 NCOR1 GORASP2 VPS52 GTF2I AHNAK VPS13A MKI67 ZNF638 TMPO KIRREL1 PDS5A SPEN PCDH9 | 4.19e-11 | 777 | 187 | 23 | 35844135 | |
| Pubmed | KIF13B CACNA1C FLNC PHACTR2 ANK2 PSMA6 ATP10B AHCYL2 EPB41L3 LRRC43 ANKLE2 HNRNPF NCOR1 GRPEL1 SETD5 AHNAK YLPM1 VPS13A TMPO CC2D2A DLD MACF1 BOD1L1 DLEC1 MYOM2 SPEN ATP2A1 DNAH8 IMMT MED13 BBOF1 | 4.62e-11 | 1442 | 187 | 31 | 35575683 | |
| Pubmed | PRTG VSIG2 PSG1 PSG3 MCAM NECTIN3 CSF1R HMCN1 KIRREL1 SIGLEC1 LRIT1 CNTN1 | 9.12e-11 | 162 | 187 | 12 | 25826454 | |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | GPHN ZNF131 ANK2 L3MBTL2 PSMA6 DIDO1 EPB41L3 GPRIN1 HNRNPF AKAP12 SETD2 GORASP2 GTF2I ALMS1 AHNAK YLPM1 MKI67 ZNF638 TMPO DLD MACF1 BOD1L1 OGA SON | 2.71e-10 | 934 | 187 | 24 | 33916271 |
| Pubmed | NRBP1 ZNF131 ANK2 L3MBTL2 MAP2 PDHA1 ATP13A1 POLR1C ETFB CEP192 EPB41L3 GPRIN1 ANKLE2 AKAP12 SPICE1 EFR3A WDR19 GRPEL1 VPS13A TMPO DLD KIRREL1 MACF1 AKAP13 CRYBG3 TMX3 OGA IMMT MAST3 | 1.96e-09 | 1487 | 187 | 29 | 33957083 | |
| Pubmed | FLNC ZFAT ANK2 MYOM1 GIT1 CMYA5 ARMCX2 CCDC141 CLIP1 AKAP12 NCOR1 ALMS1 MACF1 MYOM2 ATP2A1 MED13 SON | 1.97e-09 | 497 | 187 | 17 | 23414517 | |
| Pubmed | MCAM RNF213 NBEA CEP192 GPRIN1 ANKLE2 SPICE1 EFR3A NCOR1 NCOR2 GRPEL1 GORASP2 WASHC5 AHNAK SVIL YLPM1 VPS13A MKI67 ZNF638 LBH TMPO PINX1 KIRREL1 CRYBG3 | 2.68e-09 | 1049 | 187 | 24 | 27880917 | |
| Pubmed | GPHN FLNC SNPH ANK2 GIT1 MAP2 PDHA1 TNC PSMA6 ETFB NBEA GABARAPL2 EPB41L3 ARHGEF11 HNRNPF ITPKB USP5 KCND3 WASHC5 VCAN SVIL TMPO DLD MACF1 TNR IMMT KNG1 CNTN1 | 3.58e-09 | 1431 | 187 | 28 | 37142655 | |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | ZNF131 NCOA6 DIDO1 EPB41L3 HNRNPF NCOR1 NCOR2 SETD2 GTF2I SLC35F3 AHNAK YLPM1 MKI67 ZNF638 TMPO PINX1 PDS5A BOD1L1 SPEN ATP2A1 IMMT SON | 1.13e-08 | 954 | 187 | 22 | 36373674 |
| Pubmed | 3.52e-08 | 60 | 187 | 7 | 19075228 | ||
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | GPHN KIF13B NCOA6 PHACTR2 GIT1 MAP2 CEP192 EPB41L3 DENND4C MEX3C SPICE1 ITPKB ALMS1 AHNAK SVIL MACF1 AKAP13 BOD1L1 CRYBG3 RASSF8 | 4.86e-08 | 861 | 187 | 20 | 36931259 |
| Pubmed | ANK2 PSMA6 ETFB EPB41L3 GPRIN1 ANKLE2 HNRNPF DENND4C AKAP12 SPICE1 EFR3A AHNAK TMPO MACF1 PDS5A BOD1L1 CRYBG3 IMMT | 6.23e-08 | 708 | 187 | 18 | 39231216 | |
| Pubmed | HDAC9 KIF13B ATP13A1 SYTL2 RNF213 ARMCX2 EPB41L3 CLSTN1 SETD2 FAT2 ATP2C1 ALMS1 MACF1 PDS5A MAST3 | 8.41e-08 | 493 | 187 | 15 | 15368895 | |
| Pubmed | FLNC PDHA1 DIDO1 EPB41L3 HNRNPF USP5 GTF2I AHNAK YLPM1 MKI67 ZNF638 DLD MACF1 PDS5A SPEN IMMT SON | 1.05e-07 | 653 | 187 | 17 | 22586326 | |
| Pubmed | A2M NCOA6 FLNC MAN2B1 PSG3 SYTL2 MCAM ANKLE2 CISH RNF14 NCOR1 NCOR2 USP5 YLPM1 MACF1 SON | 1.50e-07 | 591 | 187 | 16 | 15231748 | |
| Pubmed | Tenascin-C, tenascin-R and tenascin-X: a family of talented proteins in search of functions. | 1.53e-07 | 3 | 187 | 3 | 7694605 | |
| Pubmed | 1.53e-07 | 3 | 187 | 3 | 7530141 | ||
| Pubmed | 1.67e-07 | 257 | 187 | 11 | 16335952 | ||
| Pubmed | ACTR5 RNF213 REV3L EPB41L3 C11orf16 POLR1G DMAP1 NCOR2 SETD2 VPS52 ATP2C1 HMCN2 ALMS1 SLC35F3 SETD5 MACF1 SIGLEC1 CRYBG3 TAF4B TMX3 KAT6B SON | 1.74e-07 | 1116 | 187 | 22 | 31753913 | |
| Pubmed | GPHN KIF13B ANK2 GIT1 DIDO1 NBEA EPB41L3 ARHGEF11 CLIP1 AKAP12 SPICE1 NCOR1 NCOR2 SPHKAP SVIL YLPM1 PAK1 MACF1 TNR CNTN1 | 2.91e-07 | 963 | 187 | 20 | 28671696 | |
| Pubmed | GPHN IFT27 FLNC POLR1C HNRNPF NCOR2 SETD2 GTF2I AHNAK YLPM1 MKI67 BOD1L1 SON | 2.91e-07 | 399 | 187 | 13 | 35987950 | |
| Pubmed | ZFAT DIDO1 ZSWIM6 JADE1 ANKLE2 NCOR1 NCOR2 USP5 MKI67 MACF1 AKAP13 KAT6B | 3.10e-07 | 335 | 187 | 12 | 15741177 | |
| Pubmed | TRIM33 drives prostate tumor growth by stabilizing androgen receptor from Skp2-mediated degradation. | 3.56e-07 | 220 | 187 | 10 | 35785414 | |
| Pubmed | Menin and Menin-Associated Proteins Coregulate Cancer Energy Metabolism. | KIF13B NCOA6 RNF213 DIDO1 GRHL2 NCOR1 YLPM1 MKI67 ZNF638 PDS5A KAT6B SPEN | 3.74e-07 | 341 | 187 | 12 | 32971831 |
| Pubmed | CACNA1C ANK2 GIT1 MAP2 TNC SYTL2 NBEA AHCYL2 EPB41L3 GPRIN1 PAK1 MACF1 | 4.50e-07 | 347 | 187 | 12 | 17114649 | |
| Pubmed | 5.58e-07 | 130 | 187 | 8 | 12421765 | ||
| Pubmed | 6.09e-07 | 4 | 187 | 3 | 16192278 | ||
| Pubmed | 6.09e-07 | 4 | 187 | 3 | 12972258 | ||
| Pubmed | 6.09e-07 | 4 | 187 | 3 | 34504132 | ||
| Pubmed | Targeting TRIM37-driven centrosome dysfunction in 17q23-amplified breast cancer. | 7.54e-07 | 184 | 187 | 9 | 32908313 | |
| Pubmed | 9.86e-07 | 246 | 187 | 10 | 15345747 | ||
| Pubmed | Glycoproteomics Reveals Decorin Peptides With Anti-Myostatin Activity in Human Atrial Fibrillation. | 9.92e-07 | 97 | 187 | 7 | 27559042 | |
| Pubmed | 1.35e-06 | 146 | 187 | 8 | 27068509 | ||
| Pubmed | 1.52e-06 | 5 | 187 | 3 | 11038354 | ||
| Pubmed | Combinatorial roles of the nuclear receptor corepressor in transcription and development. | 1.52e-06 | 5 | 187 | 3 | 11030619 | |
| Pubmed | 1.52e-06 | 5 | 187 | 3 | 24920589 | ||
| Pubmed | Cell-Type-Specific Alternative Splicing Governs Cell Fate in the Developing Cerebral Cortex. | 1.61e-06 | 37 | 187 | 5 | 27565344 | |
| Pubmed | Detailed comparative map of human chromosome 19q and related regions of the mouse genome. | 1.69e-06 | 67 | 187 | 6 | 8812484 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | CACNA1C MAP2 PCDH11Y RNF213 CEP192 AHCYL2 ZSWIM6 GRHL2 HNRNPF ITPKB NCOR2 PPARGC1B ATP2C1 GTF2I KCND3 SETD5 ABCC8 ZNF638 MACF1 AKAP13 BOD1L1 CAMTA1 TMX3 KAT6B | 1.70e-06 | 1489 | 187 | 24 | 28611215 |
| Pubmed | GPHN NCOA6 DIDO1 GPRIN1 DMAP1 NCOR1 SETD2 GTF2I ALMS1 AHNAK YLPM1 TMPO BOD1L1 SPEN | 1.86e-06 | 549 | 187 | 14 | 38280479 | |
| Pubmed | FLNC PHACTR2 ANK2 TNFRSF14 NBEA EPB41L3 ARHGEF11 VPS13A MKI67 TMPO SPEN | 1.90e-06 | 329 | 187 | 11 | 17474147 | |
| Pubmed | SNPH FRMPD4 CEP192 AHCYL2 ZSWIM6 SETD5 SPHKAP MACF1 BOD1L1 CAMTA1 SPEN SON | 2.38e-06 | 407 | 187 | 12 | 12693553 | |
| Pubmed | POLR1C HNRNPF VPS52 GTF2I MKI67 TMPO PDS5A BOD1L1 MED13 ACSL5 | 2.43e-06 | 272 | 187 | 10 | 31010829 | |
| Pubmed | PSMA6 POLR1C RNF213 DIDO1 POLR1G DMAP1 NCOR1 NCOR2 USP5 SETD2 GTF2I AHNAK YLPM1 MKI67 PDS5A BOD1L1 IMMT MED13 SON | 2.66e-06 | 1014 | 187 | 19 | 32416067 | |
| Pubmed | Fibril treatment changes protein interactions of tau and α-synuclein in human neurons. | MAP2 NBEA EPB41L3 GPRIN1 HNRNPF VPS52 AHNAK VCAN SVIL PAK1 TMPO MACF1 BOD1L1 | 3.41e-06 | 498 | 187 | 13 | 36634849 |
| Pubmed | Mapping the Ku Interactome Using Proximity-Dependent Biotin Identification in Human Cells. | 3.46e-06 | 283 | 187 | 10 | 30585729 | |
| Pubmed | Interaction network of human early embryonic transcription factors. | ZNF131 NCOA6 L3MBTL2 DMAP1 NCOR1 NCOR2 ALMS1 MKI67 ATF3 SPEN IMMT | 3.54e-06 | 351 | 187 | 11 | 38297188 |
| Pubmed | A2M PSMA6 ETFB DIDO1 CLIP1 DMAP1 NCOR2 USP5 SETD2 ATP2C1 MKI67 ZNF638 TMCO3 OGA PCDH9 IMMT | 3.62e-06 | 754 | 187 | 16 | 35906200 | |
| Pubmed | GPHN FRMPD4 ANK2 GIT1 MAP2 PDHA1 ATP13A1 ETFB NBEA AHCYL2 EPB41L3 GPRIN1 ANKLE2 ATP2C1 KCND3 WASHC5 SPHKAP DLD MACF1 CRYBG3 | 3.80e-06 | 1139 | 187 | 20 | 36417873 | |
| Pubmed | GPHN MCAM NBEA GPRIN1 ANKLE2 DENND4C AKAP12 GORASP2 WASHC5 VPS13A TMPO IMMT ATP4A | 3.88e-06 | 504 | 187 | 13 | 34432599 | |
| Pubmed | A high-throughput approach for measuring temporal changes in the interactome. | GPHN NRBP1 FLNC MAN2B1 GIT1 MAP2 PDHA1 PSMA6 POLR1C CMYA5 CLIP1 HNRNPF AKAP12 LIG1 USP5 GRPEL1 GORASP2 GTF2I WASHC5 AHNAK DLD MACF1 OGA | 3.93e-06 | 1455 | 187 | 23 | 22863883 |
| Pubmed | 3.96e-06 | 225 | 187 | 9 | 25277244 | ||
| Pubmed | 5.27e-06 | 7 | 187 | 3 | 3643793 | ||
| Pubmed | 5.27e-06 | 7 | 187 | 3 | 11867749 | ||
| Pubmed | 5.27e-06 | 7 | 187 | 3 | 37174615 | ||
| Pubmed | HDAC9 NRBP1 ANK2 GIT1 ATP13A1 LONRF1 POLR1C NBEA REV3L CMYA5 HNRNPF RYR3 DMAP1 WDR19 GORASP2 TXNDC15 YLPM1 PAK1 MACF1 IMMT MED13 | 6.46e-06 | 1285 | 187 | 21 | 35914814 | |
| Pubmed | KSHV episome tethering sites on host chromosomes and regulation of latency-lytic switch by CHD4. | 7.02e-06 | 130 | 187 | 7 | 35545047 | |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | NCOA6 L3MBTL2 ACTR5 POLR1C DIDO1 POLR1G HNRNPF DMAP1 NCOR1 NCOR2 SETD2 GTF2I AHNAK YLPM1 MKI67 ZNF638 TMPO PDS5A ATF3 SPEN SON | 7.18e-06 | 1294 | 187 | 21 | 30804502 |
| Pubmed | MYC multimers shield stalled replication forks from RNA polymerase. | FLNC PDHA1 POLR1C DIDO1 POLR1G HNRNPF DMAP1 LIG1 NCOR2 GTF2I AHNAK YLPM1 MKI67 ZNF638 TMPO PINX1 BOD1L1 SON | 7.34e-06 | 989 | 187 | 18 | 36424410 |
| Pubmed | Automated yeast two-hybrid screening for nuclear receptor-interacting proteins. | 8.16e-06 | 133 | 187 | 7 | 15604093 | |
| Pubmed | Stereocilin connects outer hair cell stereocilia to one another and to the tectorial membrane. | 8.40e-06 | 8 | 187 | 3 | 21165971 | |
| Pubmed | 8.40e-06 | 8 | 187 | 3 | 11784029 | ||
| Pubmed | MCAM NECTIN3 EPB41L3 BLZF1 AKAP12 EFR3A GORASP2 TMPO KIRREL1 MACF1 PCDH9 CD276 | 9.57e-06 | 467 | 187 | 12 | 30194290 | |
| Pubmed | ZNF131 NCOA6 L3MBTL2 ACTR5 PSMA6 DIDO1 CEP192 DMAP1 NCOR1 NCOR2 GRPEL1 GTF2I ALMS1 SVIL YLPM1 MKI67 ZNF638 DLD PDS5A RASSF8 SPEN IMMT | 9.79e-06 | 1429 | 187 | 22 | 35140242 | |
| Pubmed | 9.85e-06 | 191 | 187 | 8 | 31177093 | ||
| Pubmed | NCOA6 MXRA5 PDHA1 TNC MUC16 NBEA REV3L ITPKB WDR19 NCOR1 NCOR2 VPS13A ATF3 SPEN | 1.03e-05 | 638 | 187 | 14 | 31182584 | |
| Pubmed | L3MBTL2 ATP13A1 SYTL2 RNF213 NECTIN3 DENND4C SETD2 GORASP2 VPS52 ALMS1 YLPM1 ZNF638 KIRREL1 AKAP13 BOD1L1 | 1.13e-05 | 733 | 187 | 15 | 34672954 | |
| Pubmed | E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins. | LAMB4 MXRA5 RNF213 NBEA REV3L GPRIN1 HNRNPF AHNAK VPS13A TMPO PDS5A AKAP13 BOD1L1 TNR ALOX5 | 1.19e-05 | 736 | 187 | 15 | 29676528 |
| Pubmed | Human HDAC7 histone deacetylase activity is associated with HDAC3 in vivo. | 1.25e-05 | 9 | 187 | 3 | 11466315 | |
| Pubmed | 1.39e-05 | 263 | 187 | 9 | 34702444 | ||
| Pubmed | Identification of SUMO Binding Proteins Enriched after Covalent Photo-Cross-Linking. | RNF213 DIDO1 NCOR1 USP5 GTF2I AHNAK ZNF638 TMPO PDS5A BOD1L1 | 1.40e-05 | 332 | 187 | 10 | 32786267 |
| Pubmed | PDHA1 POLR1C ARHGEF11 HNRNPF EFR3A AHNAK SVIL YLPM1 MKI67 TMPO DLD KIRREL1 MACF1 IMMT | 1.50e-05 | 660 | 187 | 14 | 32780723 | |
| Pubmed | 1.56e-05 | 267 | 187 | 9 | 33417871 | ||
| Pubmed | A2M SNPH L3MBTL2 MAP2 C2orf88 EPB41L3 POLR1G USP5 SETD2 TMPO MACF1 TAF4B | 1.74e-05 | 496 | 187 | 12 | 31343991 | |
| Pubmed | ACF7 regulates cytoskeletal-focal adhesion dynamics and migration and has ATPase activity. | 1.79e-05 | 10 | 187 | 3 | 18854161 | |
| Pubmed | 1.85e-05 | 101 | 187 | 6 | 10997877 | ||
| Pubmed | Analysis of BCL6-interacting proteins by tandem mass spectrometry. | 2.15e-05 | 62 | 187 | 5 | 16147992 | |
| Pubmed | 2.19e-05 | 104 | 187 | 6 | 9205841 | ||
| Pubmed | 2.32e-05 | 215 | 187 | 8 | 35973513 | ||
| Pubmed | Synaptic GAP and GEF Complexes Cluster Proteins Essential for GTP Signaling. | 2.34e-05 | 281 | 187 | 9 | 28706196 | |
| Pubmed | Proteome-scale mapping of binding sites in the unstructured regions of the human proteome. | NCOA6 BLZF1 CCDC141 NCOR1 NCOR2 YLPM1 PAK1 AKAP13 CAMTA1 SPEN SON | 2.36e-05 | 430 | 187 | 11 | 35044719 |
| Pubmed | Versican facilitates chondrocyte differentiation and regulates joint morphogenesis. | 2.45e-05 | 11 | 187 | 3 | 20404343 | |
| Pubmed | Sharp, an inducible cofactor that integrates nuclear receptor repression and activation. | 2.45e-05 | 11 | 187 | 3 | 11331609 | |
| Pubmed | 2.45e-05 | 11 | 187 | 3 | 31776257 | ||
| Pubmed | 2.61e-05 | 285 | 187 | 9 | 21423176 | ||
| Pubmed | 2.71e-05 | 65 | 187 | 5 | 34645483 | ||
| Pubmed | 2.79e-05 | 360 | 187 | 10 | 33111431 | ||
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | ZNF131 L3MBTL2 PSMA6 DIDO1 DMAP1 GTF2I ASF1B MKI67 TMPO PINX1 PDS5A BOD1L1 SPEN | 2.81e-05 | 608 | 187 | 13 | 36089195 |
| Pubmed | SR protein kinases promote splicing of nonconsensus introns. | 2.85e-05 | 361 | 187 | 10 | 26167880 | |
| Pubmed | Rrn3 phosphorylation is a regulatory checkpoint for ribosome biogenesis. | 2.88e-05 | 2 | 187 | 2 | 12015311 | |
| Pubmed | 2.88e-05 | 2 | 187 | 2 | 19261907 | ||
| Pubmed | 2.88e-05 | 2 | 187 | 2 | 10406848 | ||
| Pubmed | 2.88e-05 | 2 | 187 | 2 | 16493581 | ||
| Pubmed | 2.88e-05 | 2 | 187 | 2 | 9321695 | ||
| Pubmed | CREBBP Inactivation Promotes the Development of HDAC3-Dependent Lymphomas. | 2.88e-05 | 2 | 187 | 2 | 27733359 | |
| Pubmed | 2.88e-05 | 2 | 187 | 2 | 16192272 | ||
| Pubmed | Essential role of the N-terminal region of TFII-I in viability and behavior. | 2.88e-05 | 2 | 187 | 2 | 20403157 | |
| Pubmed | Tenascins and inflammation in disorders of the nervous system. | 2.88e-05 | 2 | 187 | 2 | 23269478 | |
| Interaction | TNR interactions | 1.19e-06 | 38 | 185 | 6 | int:TNR | |
| Interaction | KCTD13 interactions | GPHN FLNC LAMB4 SNPH ANK2 GIT1 MAP2 PDHA1 TNC PSMA6 POLR1C ETFB NBEA GABARAPL2 AHCYL2 EPB41L3 ARHGEF11 HNRNPF ITPKB USP5 GORASP2 KCND3 WASHC5 VCAN SVIL TMPO DLD MACF1 TNR IMMT KNG1 CNTN1 | 1.34e-06 | 1394 | 185 | 32 | int:KCTD13 |
| Interaction | KCNA3 interactions | ANK2 PSMA6 SYTL2 ETFB RNF213 PRRT2 EPB41L3 GPRIN1 ANKLE2 CLIP1 HNRNPF DENND4C AKAP12 SPICE1 EFR3A AHNAK VPS13A TMPO MACF1 PDS5A BOD1L1 CRYBG3 SPEN IMMT | 1.55e-06 | 871 | 185 | 24 | int:KCNA3 |
| Interaction | H3C1 interactions | ANK2 L3MBTL2 PDHA1 DIDO1 JADE1 POLR1G GPRIN1 DMAP1 NCOR1 GRPEL1 SETD2 ASF1B WDR87 AHNAK MKI67 PAK1 ZNF638 TMPO PINX1 PDS5A KAT6B SPEN DNAH8 | 9.15e-06 | 901 | 185 | 23 | int:H3C1 |
| Interaction | NAA40 interactions | GPHN ZNF131 ANK2 L3MBTL2 PSMA6 DIDO1 EPB41L3 GPRIN1 HNRNPF AKAP12 SETD2 GORASP2 GTF2I ALMS1 AHNAK YLPM1 MKI67 ZNF638 TMPO DLD MACF1 BOD1L1 OGA SON | 1.11e-05 | 978 | 185 | 24 | int:NAA40 |
| Interaction | ARL14 interactions | 1.43e-05 | 119 | 185 | 8 | int:ARL14 | |
| Interaction | FLOT1 interactions | ABCA1 ANK2 PDHA1 MCAM EPB41L3 GPRIN1 AKAP12 EFR3A GORASP2 SVIL KIRREL1 MACF1 BOD1L1 CRYBG3 RASSF8 | 3.45e-05 | 475 | 185 | 15 | int:FLOT1 |
| Interaction | KIF20A interactions | FLNC ZFAT ANK2 PDHA1 LONRF1 POLR1C DIDO1 POLR1G HNRNPF EFR3A ALMS1 MUC17 AHNAK SVIL YLPM1 MKI67 ZNF638 TMPO MACF1 BOD1L1 CRYBG3 ATP2A1 IMMT SON | 3.62e-05 | 1052 | 185 | 24 | int:KIF20A |
| Interaction | SMC5 interactions | ZNF131 NCOA6 DIDO1 REV3L EPB41L3 HNRNPF NCOR1 NCOR2 SETD2 GTF2I SLC35F3 AHNAK YLPM1 MKI67 ZNF638 TMPO PINX1 PDS5A BOD1L1 SPEN ATP2A1 IMMT SON | 4.71e-05 | 1000 | 185 | 23 | int:SMC5 |
| Interaction | RAC3 interactions | NRBP1 GIT1 MCAM NECTIN3 PRRT2 EPB41L3 GPRIN1 ANKLE2 AKAP12 EFR3A GORASP2 VPS13A PAK1 TMPO KIRREL1 MACF1 IMMT | 5.95e-05 | 619 | 185 | 17 | int:RAC3 |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | PRTG MXRA5 MYOM1 VSIG2 MDGA2 NECTIN3 IGFBPL1 HMCN2 HMCN1 KIRREL1 MYOM2 SIGLEC1 LRIT1 CNTN1 | 1.68e-11 | 161 | 135 | 14 | 593 |
| GeneFamily | Zinc fingers MYND-type|A-kinase anchoring proteins | 6.39e-08 | 29 | 135 | 6 | 396 | |
| GeneFamily | Immunoglobulin like domain containing | MXRA5 ICAM1 MCAM MDGA2 NECTIN3 CCDC141 CSF1R HMCN2 KIRREL1 MYOM2 CNTN1 | 2.18e-07 | 193 | 135 | 11 | 594 |
| GeneFamily | Fibronectin type III domain containing | 3.21e-06 | 160 | 135 | 9 | 555 | |
| GeneFamily | Adenosine receptors|V-set domain containing | 3.74e-06 | 163 | 135 | 9 | 590 | |
| GeneFamily | C2-set domain containing|Immunoglobulin like domain containing|Scavenger receptors | 1.15e-05 | 40 | 135 | 5 | 592 | |
| GeneFamily | Cadherin related | 2.56e-04 | 17 | 135 | 3 | 24 | |
| GeneFamily | Hyalectan proteoglycans|V-set domain containing|Sushi domain containing|C-type lectin domain containing | 3.29e-04 | 4 | 135 | 2 | 574 | |
| GeneFamily | Fibrinogen C domain containing | 8.30e-04 | 25 | 135 | 3 | 554 | |
| GeneFamily | LEM domain containing | 1.13e-03 | 7 | 135 | 2 | 1087 | |
| GeneFamily | Fibronectin type III domain containing|I-set domain containing|Myosin binding proteins | 1.50e-03 | 8 | 135 | 2 | 658 | |
| GeneFamily | Fibulins | 1.50e-03 | 8 | 135 | 2 | 556 | |
| GeneFamily | WD repeat domain containing|BEACH domain containing | 1.93e-03 | 9 | 135 | 2 | 1230 | |
| GeneFamily | ATPases Ca2+ transporting | 1.93e-03 | 9 | 135 | 2 | 1209 | |
| GeneFamily | CD molecules|V-set domain containing|Pregnancy specific glycoproteins | 2.91e-03 | 11 | 135 | 2 | 1315 | |
| GeneFamily | Non-clustered protocadherins | 3.48e-03 | 12 | 135 | 2 | 21 | |
| GeneFamily | PDZ domain containing | 5.68e-03 | 152 | 135 | 5 | 1220 | |
| GeneFamily | GATA zinc finger domain containing|Myb/SANT domain containing | 7.26e-03 | 53 | 135 | 3 | 532 | |
| Coexpression | GSE3982_MEMORY_CD4_TCELL_VS_TH2_UP | ZNF131 NCOA6 TNFRSF14 AHCYL2 CLSTN1 RYR3 CPQ MACF1 CAMTA1 KAT6B TNXB | 1.78e-07 | 196 | 187 | 11 | M5381 |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HPERIC | A2M CACNA1C ABCA1 MXRA5 VSIG2 SYTL2 MCAM RNF213 CPED1 AKAP12 ITPKB CISH PPARGC1B CPQ KLF1 SVIL LBH KIRREL1 ATF3 MYOM2 | 1.16e-06 | 795 | 187 | 20 | M39050 |
| Coexpression | GSE3982_MEMORY_CD4_TCELL_VS_TH1_UP | TNFRSF14 AHCYL2 CLSTN1 SETD2 CPQ MACF1 CAMTA1 KAT6B TNXB SON | 1.63e-06 | 197 | 187 | 10 | M5378 |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HGABA | CACNA1C FRMPD4 ANK2 COL6A6 MAP2 LONRF1 SYTL2 MDGA2 NBEA REV3L PRRT2 CCDC141 CLIP1 PPARGC1B FAT2 VCAN LBH BOD1L1 TMCO3 CAMTA1 PCDH9 CDH13 CNTN1 | 4.41e-06 | 1106 | 187 | 23 | M39071 |
| Coexpression | NABA_CORE_MATRISOME | LAMB4 MXRA5 COL6A6 TNC IGFBPL1 HMCN2 HMCN1 ACAN VCAN TNR TNXB | 4.94e-06 | 275 | 187 | 11 | M5884 |
| Coexpression | GSE13493_DP_VS_CD8POS_THYMOCYTE_UP | 1.39e-05 | 199 | 187 | 9 | M3314 | |
| Coexpression | GSE3982_CTRL_VS_IGE_STIM_MAST_CELL_DN | 1.39e-05 | 199 | 187 | 9 | M5366 | |
| Coexpression | LAKE_ADULT_KIDNEY_C27_VASCULAR_SMOOTH_MUSCLE_CELLS_AND_PERICYTES | 1.63e-05 | 155 | 187 | 8 | M39246 | |
| Coexpression | DURCHDEWALD_SKIN_CARCINOGENESIS_DN | 2.22e-05 | 265 | 187 | 10 | M1684 | |
| Coexpression | LAKE_ADULT_KIDNEY_C2_PODOCYTES | 2.29e-05 | 212 | 187 | 9 | M39221 | |
| Coexpression | GSE7509_UNSTIM_VS_FCGRIIB_STIM_MONOCYTE_DN | 2.67e-05 | 166 | 187 | 8 | M6826 | |
| Coexpression | DURCHDEWALD_SKIN_CARCINOGENESIS_DN | 2.77e-05 | 272 | 187 | 10 | MM1027 | |
| Coexpression | DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_DN | 3.13e-05 | 276 | 187 | 10 | M3063 | |
| Coexpression | NAKAYA_B_CELL_FLUMIST_AGE_18_50YO_7DY_DN | PHACTR2 ICAM1 POLR1C POLR1G GTF2I RRN3 AHNAK YLPM1 AKAP13 KAT6B ALOX5 SON | 3.20e-05 | 399 | 187 | 12 | M40939 |
| Coexpression | MURARO_PANCREAS_DUCTAL_CELL | A2M KIF13B ABCA1 PDHA1 ICAM1 MCAM RNF213 ATP10B ZSWIM6 HNRNPF CSF1R AHNAK SVIL PAK1 LBH DLD MACF1 AKAP13 ATF3 RASSF8 OGA ALOX5 CD276 | 4.27e-05 | 1276 | 187 | 23 | M39173 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | NECTIN3 REV3L ANKLE2 CLIP1 EFR3A NCOR2 SETD2 ATP2C1 VPS13A ZNF638 MACF1 PDS5A AKAP13 CRYBG3 KAT6B SPEN MED13 SON | 4.47e-05 | 856 | 187 | 18 | M4500 |
| Coexpression | XIE_LT_HSC_S1PR3_OE_UP | 5.18e-05 | 29 | 187 | 4 | M41754 | |
| Coexpression | GSE18893_TCONV_VS_TREG_2H_TNF_STIM_DN | 8.03e-05 | 194 | 187 | 8 | M7306 | |
| Coexpression | GSE37416_0H_VS_48H_F_TULARENSIS_LVS_NEUTROPHIL_DN | 8.33e-05 | 195 | 187 | 8 | M5353 | |
| Coexpression | NABA_ECM_GLYCOPROTEINS | 8.63e-05 | 196 | 187 | 8 | M3008 | |
| Coexpression | GSE2405_HEAT_KILLED_LYSATE_VS_LIVE_A_PHAGOCYTOPHILUM_STIM_NEUTROPHIL_9H_UP | 9.59e-05 | 199 | 187 | 8 | M6198 | |
| Coexpression | GSE17721_0.5H_VS_12H_CPG_BMDC_DN | 9.59e-05 | 199 | 187 | 8 | M4122 | |
| Coexpression | GSE3039_CD4_TCELL_VS_NKT_CELL_UP | 9.93e-05 | 200 | 187 | 8 | M6426 | |
| Coexpression | TOYOTA_TARGETS_OF_MIR34B_AND_MIR34C | DIDO1 JADE1 ANKLE2 LIG1 NCOR1 USP5 SETD2 PPARGC1B GTF2I ALMS1 ASF1B MKI67 | 1.10e-04 | 454 | 187 | 12 | M19927 |
| Coexpression | OUYANG_PROSTATE_CANCER_MARKERS | 1.10e-04 | 35 | 187 | 4 | MM757 | |
| Coexpression | NABA_CORE_MATRISOME | 1.47e-04 | 270 | 187 | 9 | MM17057 | |
| Coexpression | BUSSLINGER_GASTRIC_IMMUNE_CELLS | RNF213 JADE1 REV3L ANKLE2 CLIP1 ITPKB EFR3A CISH NCOR1 SETD2 SETD5 AHNAK ZNF638 LBH MACF1 PDS5A AKAP13 BOD1L1 KAT6B OGA SPEN MED13 MAST3 SON | 1.67e-04 | 1492 | 187 | 24 | M40023 |
| Coexpression | TRAVAGLINI_LUNG_ALVEOLAR_FIBROBLAST_CELL | 1.82e-04 | 164 | 187 | 7 | M41676 | |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitTestis_Sma_top-relative-expression-ranked_1000 | HDAC9 FLNC MAP2 TNC SYTL2 MUC16 RNF213 KCNE5 CEP192 REV3L ARMCX2 CCDC141 CPED1 HMCN1 KCND3 VCAN SVIL MKI67 LBH CC2D2A PCDH9 | 4.10e-06 | 777 | 184 | 21 | gudmap_dev gonad_e13.5_M_InterstitTestis_Sma_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_k-means-cluster#2_top-relative-expression-ranked_1000 | ABCA1 MAP2 REV3L EPB41L3 EFR3A GTF2I SETD5 VCAN RASSF8 OGA IMMT MED13 | 3.26e-05 | 330 | 184 | 12 | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_k2_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_500_k-means-cluster#5 | 3.67e-05 | 186 | 184 | 9 | Facebase_RNAseq_e10.5_Mandibular Arch_500_K5 | |
| CoexpressionAtlas | DevelopingKidney_e14.5 whole kidney - Wnt4 KO_emap-6674_k-means-cluster#5_top-relative-expression-ranked_1000 | PHACTR2 ANK2 MAP2 NBEA CCDC141 RNF14 NCOR1 SVIL YLPM1 LBH RASSF8 | 4.49e-05 | 288 | 184 | 11 | gudmap_developingKidney_e14.5 whole kidney - Wnt4 KO_1000_k5 |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitFLeydig_MafB_top-relative-expression-ranked_500 | FLNC MUC16 RNF213 ARMCX2 CCDC141 CPED1 HMCN1 KCND3 VCAN SVIL LBH PCDH9 | 6.77e-05 | 356 | 184 | 12 | gudmap_dev gonad_e13.5_M_InterstitFLeydig_MafB_500 |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_k-means-cluster#3_top-relative-expression-ranked_500 | 9.48e-05 | 122 | 184 | 7 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_k3_500 | |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitLeydig_MafB_k-means-cluster#2_top-relative-expression-ranked_500 | 9.85e-05 | 165 | 184 | 8 | gudmap_dev gonad_e12.5_M_InterstitLeydig_MafB_k2_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_1000 | HDAC9 CACNA1C TNC RNF213 KCNE5 MDGA2 CEP192 WDR19 ABCG4 CSF1R HMCN2 ALMS1 KLF1 YLPM1 MKI67 ZNF638 MACF1 BOD1L1 STRC PCDH9 CDH13 | 1.20e-04 | 978 | 184 | 21 | Facebase_RNAseq_e10.5_Mandibular Arch_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000 | NCOA6 PRTG MAP2 MDGA2 AHCYL2 NECTIN3 REV3L POLR1G CLIP1 IGFBPL1 WDR19 NCOR1 SETD2 ALMS1 ASF1B VPS13A MKI67 PAK1 PDS5A BOD1L1 STRC | 1.40e-04 | 989 | 184 | 21 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000 |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitFLeydig_MafB_k-means-cluster#3_top-relative-expression-ranked_1000 | FLNC SYTL2 MUC16 ARMCX2 CCDC141 CPED1 HMCN1 KCND3 VCAN LBH PCDH9 | 1.76e-04 | 336 | 184 | 11 | gudmap_dev gonad_e13.5_M_InterstitFLeydig_MafB_k3_1000 |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitFLeydig_MafB_k-means-cluster#4_top-relative-expression-ranked_500 | 1.94e-04 | 182 | 184 | 8 | gudmap_dev gonad_e13.5_M_InterstitFLeydig_MafB_k4_500 | |
| CoexpressionAtlas | kidney_P1_CapMes_Crym_top-relative-expression-ranked_100 | 2.01e-04 | 62 | 184 | 5 | gudmap_kidney_P1_CapMes_Crym_100 | |
| CoexpressionAtlas | kidney_P0_CapMes_Crym_top-relative-expression-ranked_100 | 2.16e-04 | 63 | 184 | 5 | gudmap_kidney_P0_CapMes_Crym_100 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_top-relative-expression-ranked_500 | HDAC9 ABCA1 TNC REV3L EPB41L3 RYR3 EFR3A SLC35F3 KCND3 SETD5 VCAN MED13 | 2.42e-04 | 408 | 184 | 12 | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_500 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_top-relative-expression-ranked_1000 | HDAC9 ABCA1 ANK2 MAP2 TNC REV3L EPB41L3 RYR3 EFR3A GTF2I SLC35F3 SETD5 VCAN RASSF8 OGA IMMT MED13 CNTN1 | 2.80e-04 | 818 | 184 | 18 | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_1000 |
| CoexpressionAtlas | dev gonad_e12.5_F_VasAssMesen_MafB_k-means-cluster#4_top-relative-expression-ranked_500 | 2.88e-04 | 146 | 184 | 7 | gudmap_dev gonad_e12.5_F_VasAssMesen_MafB_k4_500 | |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitTestis_Sma_top-relative-expression-ranked_200 | 3.01e-04 | 147 | 184 | 7 | gudmap_dev gonad_e13.5_M_InterstitTestis_Sma_200 | |
| CoexpressionAtlas | Endoderm Differentiated Cells_vs_Pluripotent Stem Cells-Confounder_removed-fold2.0_adjp0.05 | FLNC PHACTR2 TNC ETFB MCAM ZSWIM6 EPB41L3 CLIP1 GTF2I SLC35F3 AHNAK SVIL LBH AKAP13 RASSF8 | 3.15e-04 | 615 | 184 | 15 | PCBC_ratio_DE_vs_SC_cfr-2X-p05 |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitTestis_Sma_top-relative-expression-ranked_500 | FLNC MAP2 TNC MUC16 ARMCX2 CCDC141 CPED1 HMCN1 VCAN LBH PCDH9 | 3.25e-04 | 361 | 184 | 11 | gudmap_dev gonad_e13.5_M_InterstitTestis_Sma_500 |
| CoexpressionAtlas | geo_heart_top-relative-expression-ranked_1000_k-means-cluster#5 | A2M CACNA1C FLNC MYOM1 IL20RA CCDC141 CSF1R HMCN2 KCND3 SPHKAP MYOM2 TNXB | 3.42e-04 | 424 | 184 | 12 | geo_heart_1000_K5 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_500 | CACNA1C MDGA2 CEP192 WDR19 HMCN2 ALMS1 KLF1 YLPM1 MKI67 ZNF638 MACF1 BOD1L1 STRC | 3.76e-04 | 492 | 184 | 13 | Facebase_RNAseq_e10.5_Mandibular Arch_500 |
| ToppCell | LV-15._Ventricular_Cardiomyocyte_III|LV / Chamber and Cluster_Paper | HDAC9 CACNA1C FLNC ANK2 MYOM1 CMYA5 CCDC141 CPED1 SVIL AKAP13 MYOM2 PCDH9 CDH13 | 1.13e-12 | 184 | 187 | 13 | ab7a1620c14a9d9b6be1b47c559931e345e9eef8 |
| ToppCell | COVID-19-Heart-CM_2|COVID-19 / Disease (COVID-19 only), tissue and cell type | HDAC9 CACNA1C FLNC ANK2 MYOM1 CMYA5 CCDC141 CPED1 SPHKAP SVIL MYOM2 PCDH9 CDH13 | 1.21e-12 | 185 | 187 | 13 | 549eeb521c3985bff396ea0f202db21822efa51f |
| ToppCell | COVID-19-Heart-CM_+_EC_+_Pericyte|COVID-19 / Disease (COVID-19 only), tissue and cell type | HDAC9 CACNA1C FLNC ANK2 MYOM1 CMYA5 CCDC141 CPED1 SPHKAP MYOM2 PCDH9 CDH13 | 1.80e-11 | 181 | 187 | 12 | 719eb532453ab7cd7893726885bc75d74a10b21e |
| ToppCell | LA-13._Vascular_Smooth_Muscle|LA / Chamber and Cluster_Paper | A2M HDAC9 CACNA1C MAP2 NBEAL1 TNC SYTL2 CPED1 RYR3 HMCN2 SVIL MACF1 | 2.80e-11 | 188 | 187 | 12 | 34e1b074a3995aa46ab194eb45115d76d1a5514d |
| ToppCell | RV-06._Ventricular_Cardiomyocyte_II|World / Chamber and Cluster_Paper | CACNA1C ANK2 MYOM1 CMYA5 CCDC141 PPARGC1B KCND3 SPHKAP SVIL AKAP13 MYOM2 CDH13 | 2.98e-11 | 189 | 187 | 12 | 5e80c47f63980904c4c1ff02c201b67b456a0974 |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | ABCA1 COL6A6 NBEA REV3L EPB41L3 NCOR1 ABCC8 SPHKAP VPS13A MACF1 BOD1L1 SON | 4.29e-11 | 195 | 187 | 12 | 7796ea9247f4c63762f0de8490fed08b9717fa23 |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | ABCA1 COL6A6 NBEA REV3L EPB41L3 NCOR1 ABCC8 SPHKAP VPS13A MACF1 BOD1L1 SON | 4.29e-11 | 195 | 187 | 12 | 3e519cffa6144a62b06124642a14c9ff39b76554 |
| ToppCell | Control_saline-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|Control_saline / Treatment groups by lineage, cell group, cell type | ABCA1 ANK2 COL6A6 TNC SYTL2 CPED1 AKAP12 LPA VCAN LBH MACF1 TNXB | 5.77e-11 | 200 | 187 | 12 | bd8cf33502adea320e91ca2af14e1911d88ad374 |
| ToppCell | COVID-19-Heart-CM_1|COVID-19 / Disease (COVID-19 only), tissue and cell type | HDAC9 CACNA1C FLNC ANK2 MYOM1 CMYA5 CCDC141 CPED1 SPHKAP MYOM2 PCDH9 | 3.85e-10 | 184 | 187 | 11 | e737f0f14c49b07bbb04a165083ac32210bc5690 |
| ToppCell | LV-06._Ventricular_Cardiomyocyte_II|World / Chamber and Cluster_Paper | HDAC9 CACNA1C ANK2 MYOM1 CMYA5 CCDC141 KCND3 SPHKAP AKAP13 MYOM2 CDH13 | 5.42e-10 | 190 | 187 | 11 | de5ef606a002f85c2e0e3a36c1f259d0b85a76ff |
| ToppCell | COVID-19-Heart|COVID-19 / Disease (COVID-19 only), tissue and cell type | HDAC9 CACNA1C FLNC ANK2 MYOM1 CMYA5 CPED1 SPHKAP MYOM2 PCDH9 CDH13 | 5.42e-10 | 190 | 187 | 11 | 918ad5037881212008f9f69d5df5da91fd01422c |
| ToppCell | RV-06._Ventricular_Cardiomyocyte_II|RV / Chamber and Cluster_Paper | CACNA1C ANK2 MYOM1 CMYA5 CCDC141 KCND3 SPHKAP SVIL AKAP13 MYOM2 CDH13 | 5.42e-10 | 190 | 187 | 11 | fe8e78922c8ae928ef9a80bffd67868d5a87a091 |
| ToppCell | LV-06._Ventricular_Cardiomyocyte_II|LV / Chamber and Cluster_Paper | CACNA1C ANK2 MYOM1 CMYA5 CCDC141 KCND3 SPHKAP SVIL AKAP13 MYOM2 CDH13 | 5.73e-10 | 191 | 187 | 11 | 25f3eb34f4e70761e81e84c8a5829f216108cbc6 |
| ToppCell | COVID-19-Heart-CM_2|Heart / Disease (COVID-19 only), tissue and cell type | CACNA1C ANK2 MYOM1 CMYA5 CCDC141 CPED1 SPHKAP SVIL AKAP13 MYOM2 PCDH9 | 7.14e-10 | 195 | 187 | 11 | 75fc81bddb246dca3b437fb60827b1d4fe416405 |
| ToppCell | Parenchymal-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | A2M CACNA1C ANK2 COL6A6 CPED1 AKAP12 HMCN1 VCAN LBH TNXB CDH13 | 9.33e-10 | 200 | 187 | 11 | cf433f9b43d7db07acaf70e060f8f77c974e72f3 |
| ToppCell | COVID-19-Heart-CM_+_Macrophage|COVID-19 / Disease (COVID-19 only), tissue and cell type | HDAC9 CACNA1C FLNC ANK2 MYOM1 CMYA5 CCDC141 CPED1 MYOM2 PCDH9 | 2.88e-09 | 170 | 187 | 10 | 3f15242a1d3e4e9871d9170b2ef05842fb609c29 |
| ToppCell | RA-13._Vascular_Smooth_Muscle|RA / Chamber and Cluster_Paper | 5.87e-09 | 183 | 187 | 10 | 818fd886e0188091310825f9145fa53328f2c979 | |
| ToppCell | LV-15._Ventricular_Cardiomyocyte_III|World / Chamber and Cluster_Paper | HDAC9 CACNA1C ANK2 MYOM1 CMYA5 CCDC141 CPED1 SPHKAP MYOM2 CDH13 | 6.51e-09 | 185 | 187 | 10 | 6baccb26f999145e51b91d94315bf8d4655bef31 |
| ToppCell | RV-15._Ventricular_Cardiomyocyte_III|World / Chamber and Cluster_Paper | 7.99e-09 | 189 | 187 | 10 | 0a82931b5f6c0a6427ca3edd5e2235ac49099d40 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 7.99e-09 | 189 | 187 | 10 | 7fbe855bfdb47d35e040b04a80fe4b729a3764e8 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 7.99e-09 | 189 | 187 | 10 | 06b35abecd29f902cf251fcc1f6ad33db7ab08a2 | |
| ToppCell | LA-13._Vascular_Smooth_Muscle|World / Chamber and Cluster_Paper | 7.99e-09 | 189 | 187 | 10 | 6b3e88751b95fc2173f2c3d5061ed632d0c5f01c | |
| ToppCell | RV-15._Ventricular_Cardiomyocyte_III|RV / Chamber and Cluster_Paper | 8.41e-09 | 190 | 187 | 10 | 93c3188dfeb0b2f9889f8ae9b9c1f2f34129c99b | |
| ToppCell | LV-04._Ventricular_Cardiomyocyte_I|LV / Chamber and Cluster_Paper | ANK2 MYOM1 CMYA5 CCDC141 CPED1 KCND3 SPHKAP SVIL MYOM2 CDH13 | 9.29e-09 | 192 | 187 | 10 | ad19e2c1d36a0566c9b12ced10db78f4781c8ea6 |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.19e-08 | 197 | 187 | 10 | fdb92985f7df0c280b87d3e43c2394e70786a2c7 | |
| ToppCell | Bronchial-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_pulmonary|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.19e-08 | 197 | 187 | 10 | bf0520a94ebb1d2f94de9f526d17e0b0e8fe7052 | |
| ToppCell | COVID-19-lung-Fibroblast|lung / Disease (COVID-19 only), tissue and cell type | 1.25e-08 | 198 | 187 | 10 | df3de77216f5c5d6141ec44d01c56b942f611838 | |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.31e-08 | 199 | 187 | 10 | a7dd94b172c973a131a6792f8ccd9bfe44d984ac | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.31e-08 | 199 | 187 | 10 | e1849505b92820a219c5a2c35492bdd55579fb48 | |
| ToppCell | 343B-Fibroblasts-Fibroblast-G-|343B / Donor, Lineage, Cell class and subclass (all cells) | 1.31e-08 | 199 | 187 | 10 | 9c6d1c328bfbb6547f4c7bb2a784576a56bd72af | |
| ToppCell | 343B-Fibroblasts-Fibroblast-G|343B / Donor, Lineage, Cell class and subclass (all cells) | 1.31e-08 | 199 | 187 | 10 | f4b6c095cbe7a38b310adc49be4069e4d56e6a66 | |
| ToppCell | LPS_only-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_only / Treatment groups by lineage, cell group, cell type | 1.37e-08 | 200 | 187 | 10 | a7ef7022b8efcaedb7319b0b43d8c4e99d788fe2 | |
| ToppCell | Bronchial-NucSeq-Stromal-Myofibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.37e-08 | 200 | 187 | 10 | a66449b22b39dd6987fc2c3ed160d24564234ced | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.37e-08 | 200 | 187 | 10 | 311fab076f2ceb258e3970eb21e39344b894042a | |
| ToppCell | LV-13._Vascular_Smooth_Muscle|LV / Chamber and Cluster_Paper | 4.76e-08 | 171 | 187 | 9 | e99ecae66530d1ae09330cee408c8f3950b87e67 | |
| ToppCell | COVID-19-Heart-CM_3|COVID-19 / Disease (COVID-19 only), tissue and cell type | 6.10e-08 | 176 | 187 | 9 | 9df7a124ebafb0087da0cda133a394275d7bed81 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-vascular_smooth_muscle_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 6.72e-08 | 178 | 187 | 9 | 066dbc4cc2083c549d98122ed44707127f34d582 | |
| ToppCell | droplet-Marrow-nan-3m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.92e-08 | 184 | 187 | 9 | 1154a5ad7b8512272b7476f949ddac350910bfb7 | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_Arw_fibro_(16)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 9.78e-08 | 186 | 187 | 9 | 4d68ee3d32f7ef884faf402ef92b31b0eb4656f1 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.02e-07 | 187 | 187 | 9 | 15d6e158562d7d85af3ceaf955439b379c8fce81 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-glomerular_mesenchymal_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.02e-07 | 187 | 187 | 9 | f62074b631fd45ad299c69d71b09267b04d656ee | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical-aged|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.07e-07 | 188 | 187 | 9 | 32f22a4d8cb98fd8b8fa0fbf28ef9266d711d081 | |
| ToppCell | LV-04._Ventricular_Cardiomyocyte_I|World / Chamber and Cluster_Paper | 1.07e-07 | 188 | 187 | 9 | 0758b474457efa36488e0195f7357100f4b6a090 | |
| ToppCell | Control-Fibroblasts|Control / group, cell type (main and fine annotations) | 1.17e-07 | 190 | 187 | 9 | 3a42a9b98d954685d38a741f44545898d0e3e9ce | |
| ToppCell | COVID-19-kidney-vSMC/Pericyte|kidney / Disease (COVID-19 only), tissue and cell type | 1.23e-07 | 191 | 187 | 9 | fad8eaa536001b911d05ae2b12150c2398cc6f88 | |
| ToppCell | LA-03._Atrial_Cardiomyocyte|LA / Chamber and Cluster_Paper | 1.23e-07 | 191 | 187 | 9 | 5d1b674eb7703830b7ce8bbeac3363cabd0e6ae9 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive|renal_cortex_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group | 1.28e-07 | 192 | 187 | 9 | 8b86db2ebe0199fee0e9800566a619a24bfdeed5 | |
| ToppCell | COPD-Stromal-Myofibroblast|Stromal / Disease state, Lineage and Cell class | 1.28e-07 | 192 | 187 | 9 | 62904f94dfce430456f05066522cbf9bd29f4d7e | |
| ToppCell | Transplant_Alveoli_and_parenchyma-Mesenchymal-Smooth_muscle|Transplant_Alveoli_and_parenchyma / Tissue, Lineage and Cell class of Lung Cells from 10X | 1.34e-07 | 193 | 187 | 9 | 9104b572d9c3c99080e4b7455993fbb944bf117d | |
| ToppCell | COVID-19-Heart-CM_1|Heart / Disease (COVID-19 only), tissue and cell type | 1.46e-07 | 195 | 187 | 9 | f1ef50331eda8f1239dba6ea970df4eaccf032f1 | |
| ToppCell | Tracheal-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_airway_ASM|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.67e-07 | 198 | 187 | 9 | 22e766df1276c5b14aa0d83f434f47140ebb98ea | |
| ToppCell | ILEUM-inflamed-(8)_Fibroblasts|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 1.74e-07 | 199 | 187 | 9 | 3a3e2bb21cd0293622b1a975263e918d9ba24265 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.74e-07 | 199 | 187 | 9 | 30d3e8c0681ec11f86dd38c5f48d21187a1b4f90 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_pulmonary|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.74e-07 | 199 | 187 | 9 | b1753474152b82a0b811b9878c890a359e14919a | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.81e-07 | 200 | 187 | 9 | 9b0916d8d07ac2bf1739f7be5296bf77ffee6094 | |
| ToppCell | Bronchial-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.81e-07 | 200 | 187 | 9 | 389cc775c8419d90fb77cd794376d2160a7bf44e | |
| ToppCell | Parenchyma_Control_(B.)-Stromal-TX-Fibroblasts-1|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 1.81e-07 | 200 | 187 | 9 | aa1a35dcca3b799241eef4237f6eb94660e019f0 | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Fibroblasts-1|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.81e-07 | 200 | 187 | 9 | a510deaada669e690329183e18df02870bd204b3 | |
| ToppCell | Tracheal-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.81e-07 | 200 | 187 | 9 | c318d14bd6fd6f42c597eb55ac9e2f48008aeb9b | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Fibroblasts-1-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.81e-07 | 200 | 187 | 9 | dd4228cbed8a4395166a6332e08d44d88bebe3b9 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.18e-07 | 161 | 187 | 8 | 1b805f77790aeb8a71b08bfac2fe2eed7343258f | |
| ToppCell | LV-13._Vascular_Smooth_Muscle|World / Chamber and Cluster_Paper | 5.04e-07 | 165 | 187 | 8 | f37fd95adc95d7753cf6e55ae819976513c7ec77 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-vascular_smooth_muscle_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 7.54e-07 | 174 | 187 | 8 | 015d3742d3d79a57413a333f00ef2d380a9848dd | |
| ToppCell | NS-moderate-d_07-13-Lymphoid-NK|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 7.87e-07 | 175 | 187 | 8 | f6cd24d22f62469319f9d244e3e5de527d3d4d94 | |
| ToppCell | RV-03._Atrial_Cardiomyocyte|World / Chamber and Cluster_Paper | 8.57e-07 | 122 | 187 | 7 | 1cb1dd03b2aaedbe04f3ed907568c3b7f54767b3 | |
| ToppCell | 5'-Adult-SmallIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.57e-07 | 177 | 187 | 8 | bd602db857f37869ef76d14c05ef522c509f08ee | |
| ToppCell | facs-Pancreas-Exocrine-3m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.95e-07 | 178 | 187 | 8 | fcbbcc44271515de1969b4732b6441c012693d5f | |
| ToppCell | 5'-Adult-SmallIntestine-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.73e-07 | 180 | 187 | 8 | f2f6e83127a4a415e65c76a35efa8175fbd5b5d9 | |
| ToppCell | COVID-19-Heart-CM_3|Heart / Disease (COVID-19 only), tissue and cell type | 1.06e-06 | 182 | 187 | 8 | 287fcc3897ae08841f6f85ae6c9cef16f75b1dd1 | |
| ToppCell | COVID-19-Heart-CM_4|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.10e-06 | 183 | 187 | 8 | 2902b6e8aa9a6f62bc1a792c971ab7f651a8e676 | |
| ToppCell | RA-13._Vascular_Smooth_Muscle|World / Chamber and Cluster_Paper | 1.10e-06 | 183 | 187 | 8 | cae2ee08f985a6f005b4b8e959e465350315156a | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.15e-06 | 184 | 187 | 8 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.15e-06 | 184 | 187 | 8 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.15e-06 | 184 | 187 | 8 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_Arw_fibro_(16)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.20e-06 | 185 | 187 | 8 | 7dcdc009c5681ee05dd18968f7e85c3403fe34af | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell-D175|Adult / Lineage, Cell type, age group and donor | 1.30e-06 | 187 | 187 | 8 | e15d2967aac248da3517bc2c7d1beaa1d5a0aa7f | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_Arw_fibro_(16)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.30e-06 | 187 | 187 | 8 | 5258674d0346e5c51a4b965efcdc1790c970845d | |
| ToppCell | Control-Fibroblasts-Alveolar_FB|Control / group, cell type (main and fine annotations) | 1.30e-06 | 187 | 187 | 8 | 92d468dde81125d51daf7abd4703741abe1ab91c | |
| ToppCell | (2)_Fibroblasts-(20)_Fibro-1|World / Cell class and subclass of bone marrow stroma cells in homeostatis | 1.35e-06 | 188 | 187 | 8 | 409a7b69d02e87084ca955e3fe6c77230dee8861 | |
| ToppCell | RV-04._Ventricular_Cardiomyocyte_I|RV / Chamber and Cluster_Paper | 1.40e-06 | 189 | 187 | 8 | 9c1debd65c13d63fd4f3158917d621b44b714c26 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.46e-06 | 190 | 187 | 8 | 2e88e366d377d74deb53a4ea870973ce5c6532e8 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.46e-06 | 190 | 187 | 8 | 2e592323085ba9c019d678ac2a784462ab470ed9 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.46e-06 | 190 | 187 | 8 | 0028f886c789ba238c031eae5d96acaed4af8c25 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_2_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.46e-06 | 190 | 187 | 8 | 0fea33f2dc1efa23aaa2da1c318482a52a313ff1 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-vascular_smooth_muscle_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.46e-06 | 190 | 187 | 8 | d6b3a92119b210974a32af3fe9875d60eb02761e | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.46e-06 | 190 | 187 | 8 | 445952b70abffadb6ccc1ed4bbf61a88b06b73b3 | |
| ToppCell | Mesenchymal-vascular_smooth_muscle_cell|World / Lineage, Cell type, age group and donor | 1.52e-06 | 191 | 187 | 8 | fd89fbc62aa1c73e0f659991e3bd726a0c97bd68 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.52e-06 | 191 | 187 | 8 | 6688cee34beee4f151ac17fccbc9c26a9aad72e1 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m-Mesenchymal-nan|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.52e-06 | 191 | 187 | 8 | 7d1595e616f6f111fc2f5bc1b179c5d67d624cc9 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.52e-06 | 191 | 187 | 8 | 806b94f567ea09a9f443cd4091e70cdb1253ac08 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.52e-06 | 191 | 187 | 8 | 04c4d454b57e29a8d1dcdeb4678ce71bdc29b77b | |
| ToppCell | facs-Pancreas-Endocrine-3m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.58e-06 | 192 | 187 | 8 | 5b7093d5af5ae7b0e6d3a464cc56272440ecedad | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.58e-06 | 192 | 187 | 8 | 99ce9e3c4c50cf64ebb62145f2b5420efa0db309 | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Mesenchymal-Pericytes|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.64e-06 | 193 | 187 | 8 | a9349ed5f3c34dcf817b3e84737e5946922ddff3 | |
| ToppCell | background-Cholangiocytes|background / Sample and Cell Type and Tumor Cluster (all cells) | 1.64e-06 | 193 | 187 | 8 | 9152241073dbe02ac2c11d86bec9b5b529196f6e | |
| ToppCell | COVID-19-Heart-CM_+_EC_+_Pericyte|Heart / Disease (COVID-19 only), tissue and cell type | 1.64e-06 | 193 | 187 | 8 | dd5378a1ef8eb0eda9a3aae62f3c2f3a1402bda0 | |
| ToppCell | TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6|TCGA-Prostate / Sample_Type by Project: Shred V9 | 1.64e-06 | 193 | 187 | 8 | abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659 | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_adventitial_fibro_(10)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.64e-06 | 193 | 187 | 8 | cd45118ced91b10baed3b1068d4673ec99824b86 | |
| ToppCell | Control-Stromal-Myofibroblast|Stromal / Disease state, Lineage and Cell class | 1.64e-06 | 193 | 187 | 8 | 5896242f713ae5fd1a4ebb63827f15d7279dced2 | |
| ToppCell | RA-03._Atrial_Cardiomyocyte|World / Chamber and Cluster_Paper | 1.71e-06 | 194 | 187 | 8 | 89812fb164065041357bb37a3c2d87028ec3de4e | |
| Drug | 3-ethylpyridine | 2.13e-06 | 4 | 186 | 3 | CID000010823 | |
| Drug | Hydrastinine hydrochloride [4884-68-8]; Up 200; 16.4uM; HL60; HG-U133A | 5.85e-06 | 199 | 186 | 10 | 1436_UP | |
| Drug | AC1O5SNJ | 1.05e-05 | 6 | 186 | 3 | CID006439900 | |
| Drug | pyrachlostrobin | FLNC ABCA1 PHACTR2 TNC ICAM1 SYTL2 MCAM KCNE5 IGFBPL1 DENND4C AKAP12 CSF1R CPQ AHNAK SVIL MKI67 KIRREL1 ATF3 RASSF8 ALOX5 | 1.15e-05 | 811 | 186 | 20 | ctd:C513428 |
| Drug | 1-anilino-4-methyl-2-methylthio-4-phenylimidazolin-5-one | FLNC ABCA1 MAN2B1 TNC ICAM1 ETFB CCDC141 IGFBPL1 AHNAK SVIL KIRREL1 ATF3 CAMTA1 | 1.29e-05 | 373 | 186 | 13 | ctd:C540355 |
| Drug | Trichostatin A, from Streptomyces sp.; Up 200; 0.1uM; MCF7; HT_HG-U133A | 1.80e-05 | 180 | 186 | 9 | 7407_UP | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HG-U133A | 1.96e-05 | 182 | 186 | 9 | 1891_DN | |
| Drug | 2-aminoacridone | 2.31e-05 | 21 | 186 | 4 | CID000121965 | |
| Drug | AG-1478; Down 200; 31.6uM; MCF7; HT_HG-U133A_EA | 2.43e-05 | 187 | 186 | 9 | 1141_DN | |
| Drug | LY 294002; Down 200; 10uM; HL60; HT_HG-U133A | 2.64e-05 | 189 | 186 | 9 | 1168_DN | |
| Drug | PHA-00851261E [724719-49-7]; Down 200; 10uM; PC3; HT_HG-U133A | 3.12e-05 | 193 | 186 | 9 | 3773_DN | |
| Drug | chrysene | NBEAL1 TNC ICAM1 MCAM MUC16 DIDO1 AHCYL2 HNRNPF AKAP12 CISH FAT2 HMCN2 HMCN1 AHNAK MKI67 PINX1 RASSF8 OGA TNXB CDH13 | 3.19e-05 | 871 | 186 | 20 | ctd:C031180 |
| Drug | Metrizamide [31112-62-6]; Up 200; 5uM; HL60; HT_HG-U133A | 3.38e-05 | 195 | 186 | 9 | 1318_UP | |
| Drug | Benzonatate [104-31-4]; Down 200; 6.6uM; HL60; HT_HG-U133A | 3.52e-05 | 196 | 186 | 9 | 1843_DN | |
| Drug | Folic acid [59-30-3]; Down 200; 9uM; HL60; HG-U133A | 3.52e-05 | 196 | 186 | 9 | 1790_DN | |
| Drug | Hydroxytacrine maleate (R,S) [118909-22-1]; Up 200; 12.2uM; MCF7; HT_HG-U133A | 3.66e-05 | 197 | 186 | 9 | 4997_UP | |
| Drug | Naproxen [22204-53-1]; Down 200; 17.4uM; HL60; HT_HG-U133A | 3.81e-05 | 198 | 186 | 9 | 1869_DN | |
| Drug | Fenspiride hydrochloride [5053-08-7]; Up 200; 13.4uM; MCF7; HT_HG-U133A | 3.81e-05 | 198 | 186 | 9 | 2269_UP | |
| Drug | Mometasone furoate [83919-23-7]; Down 200; 7.6uM; MCF7; HT_HG-U133A | 3.96e-05 | 199 | 186 | 9 | 5541_DN | |
| Drug | Sulfinpyrazone [57-96-5]; Down 200; 9.8uM; HL60; HG-U133A | 4.12e-05 | 200 | 186 | 9 | 1574_DN | |
| Disease | parental longevity | SNPH ANK2 ATP13A1 GRHL2 RYR3 ABCC8 LPA YLPM1 VPS13A PINX1 MYOM2 LPAL2 CDH13 | 1.25e-05 | 494 | 181 | 13 | EFO_0007796 |
| Disease | Brugada Syndrome (disorder) | 1.32e-05 | 24 | 181 | 4 | C1142166 | |
| Disease | breast cancer (is_marker_for) | 1.99e-05 | 185 | 181 | 8 | DOID:1612 (is_marker_for) | |
| Disease | Prostatic Neoplasms | PDHA1 ICAM1 PCDH11Y AHCYL2 NCOR1 SETD2 VPS52 PDS5A AKAP13 ATF3 SPEN ALOX5 CDH13 CD276 | 2.94e-05 | 616 | 181 | 14 | C0033578 |
| Disease | Malignant neoplasm of prostate | PDHA1 ICAM1 PCDH11Y AHCYL2 NCOR1 SETD2 VPS52 PDS5A AKAP13 ATF3 SPEN ALOX5 CDH13 CD276 | 2.94e-05 | 616 | 181 | 14 | C0376358 |
| Disease | autosomal recessive nonsyndromic deafness 16 (implicated_via_orthology) | 3.74e-05 | 2 | 181 | 2 | DOID:0110471 (implicated_via_orthology) | |
| Disease | aspirin use measurement | 9.52e-05 | 39 | 181 | 4 | EFO_0007013 | |
| Disease | angina pectoris | 1.26e-04 | 125 | 181 | 6 | EFO_0003913 | |
| Disease | cholesteryl esters:total lipids ratio, high density lipoprotein cholesterol measurement | 1.36e-04 | 243 | 181 | 8 | EFO_0004612, EFO_0020944 | |
| Disease | Sarcomatoid Renal Cell Carcinoma | 1.43e-04 | 128 | 181 | 6 | C1266043 | |
| Disease | Chromophobe Renal Cell Carcinoma | 1.43e-04 | 128 | 181 | 6 | C1266042 | |
| Disease | Collecting Duct Carcinoma of the Kidney | 1.43e-04 | 128 | 181 | 6 | C1266044 | |
| Disease | Papillary Renal Cell Carcinoma | 1.43e-04 | 128 | 181 | 6 | C1306837 | |
| Disease | Renal Cell Carcinoma | 1.43e-04 | 128 | 181 | 6 | C0007134 | |
| Disease | aortic measurement | 1.69e-04 | 251 | 181 | 8 | EFO_0020865 | |
| Disease | chylomicron measurement, very low density lipoprotein cholesterol measurement, cholesterol:total lipids ratio | 1.83e-04 | 46 | 181 | 4 | EFO_0008317, EFO_0008596, EFO_0020943 | |
| Disease | schizophrenia, anorexia nervosa | 2.16e-04 | 48 | 181 | 4 | MONDO_0005090, MONDO_0005351 | |
| Disease | response to non-steroidal anti-inflammatory, drug-induced liver injury | 2.23e-04 | 4 | 181 | 2 | EFO_0004228, EFO_0005533 | |
| Disease | lymphocyte count | HDAC9 ZNF131 ZFAT PSG1 ICAM1 RRN3P2 CDH23 ARHGEF11 CLSTN1 ANKLE2 GRHL2 ABCG4 NCOR1 SETD2 ALMS1 AHNAK BTN2A3P ZNF638 PINX1 KIRREL1 SIGLEC1 | 2.69e-04 | 1464 | 181 | 21 | EFO_0004587 |
| Disease | free cholesterol to total lipids in small HDL percentage | 2.73e-04 | 51 | 181 | 4 | EFO_0022285 | |
| Disease | body weight | CACNA1C ZFAT NBEAL1 MDGA2 CEP192 ZSWIM6 POLR1G CLIP1 MEX3C EFR3A NCOR1 SETD2 KCND3 ACAN ABCC8 SPHKAP ZNF638 KAT6B CDH13 | 2.91e-04 | 1261 | 181 | 19 | EFO_0004338 |
| Disease | Conventional (Clear Cell) Renal Cell Carcinoma | 3.14e-04 | 148 | 181 | 6 | C0279702 | |
| Disease | cholesterol:total lipids ratio, high density lipoprotein cholesterol measurement | 3.21e-04 | 276 | 181 | 8 | EFO_0004612, EFO_0020943 | |
| Disease | Acute Cerebrovascular Accidents | 3.41e-04 | 54 | 181 | 4 | C0751956 | |
| Disease | Peripheral Nervous System Diseases | 3.41e-04 | 54 | 181 | 4 | C4721453 | |
| Disease | Malignant neoplasm of breast | NCOA6 ANK2 EPB41L3 CLIP1 AKAP12 NCOR1 SETD2 PPARGC1B TXNDC15 CSF1R MKI67 PAK1 MACF1 BOD1L1 DLEC1 KAT6B SPEN | 3.51e-04 | 1074 | 181 | 17 | C0006142 |
| Disease | Pyruvate dehydrogenase complex deficiency | 3.70e-04 | 5 | 181 | 2 | cv:C0034345 | |
| Disease | coronary atherosclerosis measurement | 3.70e-04 | 5 | 181 | 2 | EFO_0007938 | |
| Disease | migraine disorder | 3.81e-04 | 357 | 181 | 9 | MONDO_0005277 | |
| Disease | cleft lip | 3.88e-04 | 284 | 181 | 8 | EFO_0003959 | |
| Disease | Colorectal Carcinoma | FLNC ABCA1 ANK2 MAP2 AKAP12 LIG1 KCND3 ABCC8 VPS13A MKI67 DNAH8 ACSL5 CNTN1 | 4.20e-04 | 702 | 181 | 13 | C0009402 |
| Disease | Cardiac Arrhythmia | 4.73e-04 | 25 | 181 | 3 | C0003811 | |
| Disease | Atherosclerosis | 4.79e-04 | 59 | 181 | 4 | C0004153 | |
| Disease | Atherogenesis | 4.79e-04 | 59 | 181 | 4 | C1563937 | |
| Disease | triglycerides to total lipids in large HDL percentage | 5.11e-04 | 60 | 181 | 4 | EFO_0022330 | |
| Disease | cholesterol to total lipids in IDL percentage | 5.11e-04 | 60 | 181 | 4 | EFO_0022233 | |
| Disease | free cholesterol to total lipids in medium HDL percentage | 5.11e-04 | 60 | 181 | 4 | EFO_0022282 | |
| Disease | peripheral neuropathy, response to bortezomib | 5.52e-04 | 6 | 181 | 2 | EFO_0003100, EFO_0007808 | |
| Disease | Cerebrovascular accident | 5.79e-04 | 62 | 181 | 4 | C0038454 | |
| Disease | cholangiocarcinoma (is_marker_for) | 6.53e-04 | 64 | 181 | 4 | DOID:4947 (is_marker_for) | |
| Disease | high density lipoprotein particle size measurement | 6.55e-04 | 170 | 181 | 6 | EFO_0008592 | |
| Disease | factor XI measurement, coronary artery disease | 7.32e-04 | 115 | 181 | 5 | EFO_0001645, EFO_0004694 | |
| Disease | total lipids in very large HDL measurement | 7.34e-04 | 66 | 181 | 4 | EFO_0022312 | |
| Disease | arabinose measurement | 7.70e-04 | 7 | 181 | 2 | EFO_0021030 | |
| Disease | lipoprotein A measurement, apolipoprotein A 1 measurement | 7.70e-04 | 7 | 181 | 2 | EFO_0004614, EFO_0006925 | |
| Disease | apolipoprotein A 1 measurement | ABCA1 PSG1 ETFB LRRC43 NCOR2 PPARGC1B MUC17 LPA YLPM1 LBH PINX1 MACF1 DLEC1 LPAL2 | 7.85e-04 | 848 | 181 | 14 | EFO_0004614 |
| Disease | cholesterol in very large HDL measurement | 8.68e-04 | 69 | 181 | 4 | EFO_0022229 | |
| Disease | blood pressure, chronic obstructive pulmonary disease | 9.88e-04 | 32 | 181 | 3 | EFO_0000341, EFO_0004325 | |
| Disease | Leigh syndrome | 1.02e-03 | 8 | 181 | 2 | cv:C0023264 | |
| Disease | diffuse large B-cell lymphoma (is_marker_for) | 1.02e-03 | 8 | 181 | 2 | DOID:0050745 (is_marker_for) | |
| Disease | joint hypermobility measurement | 1.08e-03 | 33 | 181 | 3 | EFO_0007905 | |
| Disease | free cholesterol to total lipids in large LDL percentage | 1.13e-03 | 74 | 181 | 4 | EFO_0022280 | |
| Disease | Middle Cerebral Artery Embolus | 1.18e-03 | 34 | 181 | 3 | C0751845 | |
| Disease | Embolic Infarction, Middle Cerebral Artery | 1.18e-03 | 34 | 181 | 3 | C0751847 | |
| Disease | Left Middle Cerebral Artery Infarction | 1.18e-03 | 34 | 181 | 3 | C0751846 | |
| Disease | Right Middle Cerebral Artery Infarction | 1.18e-03 | 34 | 181 | 3 | C0751849 | |
| Disease | Thrombotic Infarction, Middle Cerebral Artery | 1.18e-03 | 34 | 181 | 3 | C0751848 | |
| Disease | Vasodilators used in cardiac diseases use measurement | 1.18e-03 | 34 | 181 | 3 | EFO_0009926 | |
| Disease | Middle Cerebral Artery Occlusion | 1.18e-03 | 34 | 181 | 3 | C0740391 | |
| Disease | Infarction, Middle Cerebral Artery | 1.18e-03 | 34 | 181 | 3 | C0740392 | |
| Disease | Middle Cerebral Artery Thrombosis | 1.18e-03 | 34 | 181 | 3 | C0740376 | |
| Disease | Middle Cerebral Artery Syndrome | 1.18e-03 | 34 | 181 | 3 | C0238281 | |
| Disease | left ventricular mass index | 1.18e-03 | 34 | 181 | 3 | EFO_0009290 | |
| Disease | chylomicron measurement, triglycerides:total lipids ratio, very low density lipoprotein cholesterol measurement | 1.18e-03 | 34 | 181 | 3 | EFO_0008317, EFO_0008596, EFO_0020947 | |
| Disease | unipolar depression | GPHN L3MBTL2 TNC RNF213 MDGA2 ITPKB VCAN SVIL YLPM1 ZNF638 DLD CAMTA1 TNR PCDH9 CDH13 CNTN1 CD276 | 1.27e-03 | 1206 | 181 | 17 | EFO_0003761 |
| Disease | response to clopidogrel, response to acetylsalicylate, major adverse cardiovascular event measurement | 1.31e-03 | 9 | 181 | 2 | EFO_0020863, GO_1903492, GO_1903493 | |
| Disease | thoracic aortic calcification measurement | 1.31e-03 | 9 | 181 | 2 | EFO_0010273 | |
| Disease | neutrophil percentage of leukocytes | HDAC9 PSG1 ATP13A1 CDH23 ABCG4 SETD2 CSF1R KLF1 PINX1 AKAP13 TMCO3 | 1.44e-03 | 610 | 181 | 11 | EFO_0007990 |
| Disease | free cholesterol in large HDL measurement | 1.44e-03 | 79 | 181 | 4 | EFO_0022157 | |
| Disease | cholesterol in large HDL measurement | 1.51e-03 | 80 | 181 | 4 | EFO_0021900 | |
| Disease | psoriasis | 1.54e-03 | 273 | 181 | 7 | EFO_0000676 | |
| Disease | Nonsyndromic Deafness | 1.58e-03 | 81 | 181 | 4 | C3711374 | |
| Disease | tenascin measurement | 1.63e-03 | 10 | 181 | 2 | EFO_0008296 | |
| Disease | nitric oxide exhalation measurement | 1.64e-03 | 38 | 181 | 3 | EFO_0005536 | |
| Disease | lung cancer (is_marker_for) | 1.76e-03 | 39 | 181 | 3 | DOID:1324 (is_marker_for) | |
| Disease | Hypercholesterolemia | 1.76e-03 | 39 | 181 | 3 | C0020443 | |
| Disease | phosphatidylcholine measurement | 1.93e-03 | 284 | 181 | 7 | EFO_0010226 | |
| Disease | gastrointestinal stromal tumor (is_implicated_in) | 1.98e-03 | 11 | 181 | 2 | DOID:9253 (is_implicated_in) | |
| Disease | stroke | 1.99e-03 | 144 | 181 | 5 | EFO_0000712 | |
| Disease | cholesterol:total lipids ratio, low density lipoprotein cholesterol measurement | 1.99e-03 | 144 | 181 | 5 | EFO_0004611, EFO_0020943 | |
| Disease | Hereditary hearing loss and deafness | 2.11e-03 | 146 | 181 | 5 | cv:C0236038 | |
| Disease | descending aortic diameter | 2.14e-03 | 88 | 181 | 4 | EFO_0021788 | |
| Disease | aortic stenosis, aortic valve calcification | 2.19e-03 | 42 | 181 | 3 | EFO_0000266, EFO_0005239 | |
| Disease | neovascular inflammatory vitreoretinopathy (is_marker_for) | 2.37e-03 | 12 | 181 | 2 | DOID:9719 (is_marker_for) | |
| Disease | breast cancer (is_implicated_in) | 2.37e-03 | 150 | 181 | 5 | DOID:1612 (is_implicated_in) | |
| Disease | gait measurement | 2.37e-03 | 150 | 181 | 5 | EFO_0007680 | |
| Disease | lean body mass | 2.46e-03 | 379 | 181 | 8 | EFO_0004995 | |
| Disease | hippocampal volume | 2.48e-03 | 297 | 181 | 7 | EFO_0005035 | |
| Disease | QRS duration | 2.52e-03 | 298 | 181 | 7 | EFO_0005055 | |
| Disease | platelet component distribution width | HDAC9 CACNA1C NCOR2 SETD2 SVIL MACF1 PDS5A AKAP13 DLEC1 SIGLEC1 CAMTA1 TNXB | 2.53e-03 | 755 | 181 | 12 | EFO_0007984 |
| Disease | reaction time measurement | ZFAT ATP13A1 CEP192 EFR3A SETD2 ZNF638 CC2D2A ANO7 CAMTA1 CDH13 CNTN1 | 2.58e-03 | 658 | 181 | 11 | EFO_0008393 |
| Disease | Neurodevelopmental Disorders | 2.61e-03 | 93 | 181 | 4 | C1535926 | |
| Disease | saturated fatty acids measurement | 2.67e-03 | 45 | 181 | 3 | EFO_0022304 | |
| Disease | hydroxy-leucine measurement | 2.67e-03 | 45 | 181 | 3 | EFO_0005276 | |
| Disease | triglyceride measurement, very low density lipoprotein cholesterol measurement | 2.67e-03 | 224 | 181 | 6 | EFO_0004530, EFO_0008317 | |
| Disease | neuroticism measurement, cognitive function measurement | CACNA1C L3MBTL2 NBEAL1 YLPM1 ZNF638 OGA TNR PCDH9 CDH13 MAST3 | 2.71e-03 | 566 | 181 | 10 | EFO_0007660, EFO_0008354 |
| Disease | white matter hyperintensity measurement | 2.72e-03 | 302 | 181 | 7 | EFO_0005665 | |
| Disease | Bardet-Biedl Syndrome | 2.79e-03 | 13 | 181 | 2 | C0752166 | |
| Disease | cerebral amyloid deposition measurement | 2.82e-03 | 95 | 181 | 4 | EFO_0007707 | |
| Disease | Squamous cell carcinoma of esophagus | 2.82e-03 | 95 | 181 | 4 | C0279626 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| GEVVPALKEVSTPDA | 181 | Q96KV6 | |
| AVTLEDGAEPPVLTT | 21 | Q9H172 | |
| VGLNPPEEEAVTSKT | 161 | Q86XL3 | |
| AISSPEIPKGVTVIA | 1201 | Q9Y6Y1 | |
| EIPKGVTVIASTNPE | 1206 | Q9Y6Y1 | |
| TPPEGITAEVLVVTS | 141 | Q9Y646 | |
| TTEEKVPPITSTEGQ | 901 | P13611 | |
| TDEVVTLTPRIGPKV | 1116 | P13611 | |
| LPTAEVEGTKAPVEK | 2061 | P13611 | |
| SEVKEKPCVSPTVGE | 1271 | Q68DQ2 | |
| PFDVVTVTIGVETPK | 601 | A4D0V7 | |
| EKVLSKPPEGVVSEV | 486 | Q02952 | |
| PIASDEIVPGDIVSI | 311 | Q9HD20 | |
| LRDGKEVTPVSSIPV | 551 | Q9HD20 | |
| SKVVILDEPTAGVDP | 1051 | O95477 | |
| EEVEPAPIVDSGTVS | 381 | Q12802 | |
| TVSSPIEQDVVGPVS | 2446 | Q12802 | |
| TEEALKVSIVPGPGD | 881 | Q8TCU4 | |
| PEEALKVSIVSGPTE | 1591 | Q8TCU4 | |
| AEVAGSKVVPALPES | 1326 | O15085 | |
| ADVDISGPKIDVTAP | 776 | Q09666 | |
| SGPKIDVTAPDVSIE | 781 | Q09666 | |
| VDISGPKVGVEVPDV | 906 | Q09666 | |
| PKADVVVSGPKVDIE | 1151 | Q09666 | |
| VVSGPKVDIEAPDVS | 1156 | Q09666 | |
| SGPKVDVEVPDVSLE | 1286 | Q09666 | |
| VTVPKVEGEIKAPDV | 1471 | Q09666 | |
| DVVVSGPKVDVEVPD | 2076 | Q09666 | |
| VDVSVPEVEGKLEVP | 2471 | Q09666 | |
| VSGPKVDVDVPDVNI | 3181 | Q09666 | |
| VSGPKVDIDTPDIDI | 4091 | Q09666 | |
| VDVTLPKADIEISGP | 4336 | Q09666 | |
| IDVSGPKVDVDVPDV | 4681 | Q09666 | |
| AVVSSPDPIRGEVVK | 501 | Q6NUN0 | |
| DPGLPSTEDVILKTE | 636 | Q9Y2X7 | |
| VPEDPVVALVGTDAT | 251 | Q5ZPR3 | |
| VAEGTPAQTESEPKV | 46 | Q9NSE2 | |
| FSEETPGVEKPVTTV | 416 | Q9H9F9 | |
| GVVSVSPKEPFTISV | 376 | O94985 | |
| IDPEKGDIVTVVSPA | 301 | P55290 | |
| SDSSGEVVLPTIPKE | 506 | Q8ND07 | |
| PGTTLIAVAAVDPDK | 2311 | Q9H251 | |
| QKIEEVDSRIGPPSS | 206 | Q14156 | |
| TEVTEGPGVAAPTKV | 191 | Q7L311 | |
| TGESVSVIKHTEPVP | 181 | O14983 | |
| DPPRTGVKEAVTTLI | 546 | P98194 | |
| KTPSITSEAVVPEAG | 981 | O94823 | |
| EVPSVPEHGRKDTVI | 886 | P01023 | |
| KNESTVPESVTPVEG | 896 | Q6ZS30 | |
| TGTKVTVLPAEPIEI | 356 | Q8NHQ8 | |
| TPGRKVDVSDITDPL | 91 | Q96DM1 | |
| PPGVKEITDKITTDE | 26 | Q29RF7 | |
| TPEATKEVIEREAPG | 96 | Q9NQX3 | |
| SEGKTSPSPIRIEEE | 1296 | Q8WYB5 | |
| SPSPIRIEEEVKETG | 1301 | Q8WYB5 | |
| VKATSPLIEETPIGS | 1751 | Q01484 | |
| TVLIDVSPPEAEKRG | 66 | Q6IWH7 | |
| VIDTPSDGAESIPTV | 2236 | Q8WXI7 | |
| TEISKEDVTSIPGPA | 7861 | Q8WXI7 | |
| KGIITAVEPSTPTVL | 1881 | Q9Y618 | |
| VVETVPCGTVPGSKE | 201 | Q9UK17 | |
| EDRVGDSTPVSEKPV | 426 | Q9H8Y8 | |
| AVKVVELPTEEPEVG | 136 | P06870 | |
| TEEPPKSVEVTSGVQ | 26 | Q9H2G9 | |
| SSEPVPGEIIAVRVK | 661 | Q969R5 | |
| TPVEGKEPGTVALVS | 181 | Q9HAV7 | |
| KEVTISLSGPGPEIE | 241 | Q8NDA2 | |
| QSEEIPEVTSEPVKG | 371 | Q17RB8 | |
| VVPDPFVGREVTSAK | 41 | Q9UJ90 | |
| LPSIVVEPTEGEVES | 61 | Q53QV2 | |
| DPPLTGETLVVVNVS | 2356 | Q9NYQ8 | |
| VTGNITLEEKPAPTD | 731 | Q9HC56 | |
| LDTPPDSKEGIVVES | 361 | A8MUH7 | |
| PVPGSDISETQVERK | 196 | Q96BK5 | |
| EVLRQTKEEITSPPG | 4381 | Q96JB1 | |
| DEVAVPKSPFRVGVT | 1331 | Q14315 | |
| VTEPKATTVDVFLPG | 726 | Q8TET4 | |
| VTKSPEGTQALEELP | 191 | Q8WX77 | |
| TDSVPISEEGTPVLE | 1346 | O94854 | |
| ETPTIPLGSAVEAIK | 586 | Q16891 | |
| DGPVISESTPIAETI | 271 | P42167 | |
| KTRGSIPTDVEVLPT | 421 | P46013 | |
| DTPVVLVSVGADLPV | 351 | O75167 | |
| QIGPPEVALTTDEKS | 136 | Q9UHF4 | |
| VLATGPSVPSTKEEL | 391 | Q9P2V4 | |
| VPQEKSPLVTREGDT | 446 | Q7Z553 | |
| VPGVAAVPVEEETTA | 706 | P16112 | |
| AVPVEEETTAVPSGE | 711 | P16112 | |
| PVEISVLAGEEVTLP | 1086 | Q96RW7 | |
| TPTPEPAEVETRKVV | 431 | Q9UHY1 | |
| GPPVGVKVTLIEDDT | 821 | Q2VWP7 | |
| TDLEVTPPVVSGEDL | 1511 | Q14686 | |
| VKAVSETPAVPPVSE | 161 | Q13153 | |
| PTPEILSESVGEKQE | 166 | Q7Z6L0 | |
| DEKPDTSLITQGVPT | 176 | Q8NFC6 | |
| PSLIPETDAVGVTVV | 81 | Q9NVP2 | |
| SVPELVVKPGATVTL | 26 | P07333 | |
| VKTVPVPDTGDSVEL | 46 | Q9BW83 | |
| PVSGITVVKAEDFTP | 151 | Q6ISB3 | |
| TAEDPGVIAETAPSK | 251 | Q13351 | |
| AEVFLPIPETTVVTG | 741 | Q9P2K1 | |
| VTLEVEVTGFPEPTL | 1426 | Q6ZP82 | |
| PVPTLRLEGVESSEK | 2051 | Q13936 | |
| DPKDTIIDVVGAPLT | 431 | Q9NPF5 | |
| PVSLIDAVPTSAEGK | 846 | Q14CM0 | |
| DGKEVIGPSSPDLVV | 836 | Q8N3K9 | |
| PSPSVEKAVTVIDPE | 2206 | Q8N3K9 | |
| EKAVTVIDPEGTIPT | 2211 | Q8N3K9 | |
| DAPSEAPTEVGVKVL | 806 | Q12860 | |
| SDTVEGVLPSKQEPE | 206 | Q9BTC0 | |
| PVVDDVPKTTATVDT | 1141 | Q5VZ89 | |
| SLVGVVVPDTDVLPS | 581 | Q9ULC5 | |
| ETESGVLETPTVVPV | 1581 | P08519 | |
| PLGVSITKAEVAPEE | 71 | P18847 | |
| EVTPFPGITIDEDTI | 186 | P09622 | |
| VVKDPNGRTVPSDVV | 536 | O00754 | |
| VLITEVAEDSPAIGP | 256 | O43462 | |
| TSVPQIAVEGEEAVP | 1286 | O60307 | |
| TEEIKVLFIPSSPGV | 1441 | Q8TEP8 | |
| VVDPKPTTTDIGSDV | 311 | Q96J84 | |
| EPSTGGEVVLKVLDP | 191 | A4D0S4 | |
| SRIGEIKEETTVSPP | 391 | P01042 | |
| PAVGEPAEVTTTVLV | 161 | P05362 | |
| SSVDVKSEVPVGLEP | 6 | Q9UKV0 | |
| GRVEPKAEPVSSTEA | 746 | Q7Z2K8 | |
| GPIKVKTEPTEDSGI | 216 | P78347 | |
| IIEVEPGTGVIEPSE | 801 | Q9Y238 | |
| SKAETPTESVSEPEV | 191 | P18858 | |
| SISEAPLTEVAKGIP | 236 | Q9UMX9 | |
| VRSEPELPVEGTSAK | 326 | Q9P1A2 | |
| VPVPKRIVIGDASET | 451 | P20648 | |
| IEPLVPEETKQSSGE | 776 | Q9Y2J2 | |
| PTAVVAPVEKTISSE | 26 | P30622 | |
| EITPEPETSVTGDRV | 1996 | A6NMZ7 | |
| PDRVPVIVEKVSGSQ | 26 | P60520 | |
| PTTAQVTIEAEPTKV | 31 | P11464 | |
| ESAGVLAEIVKPSPS | 356 | Q8N309 | |
| IEVSIPENAPVGTSV | 286 | Q9BZA8 | |
| PTTAQVTIEAEPTKV | 31 | Q16557 | |
| TPVDTKGPVVTSNEV | 1301 | Q685J3 | |
| EVVSSIDIGPPETIS | 4171 | Q685J3 | |
| PAPELVEVEVGSTAL | 31 | P43121 | |
| LGIPVNSKEPEEVAT | 146 | P43121 | |
| ITLPVDPEGKITGEA | 141 | P52597 | |
| PVEVISAKDVPTGGI | 1006 | Q9NQT8 | |
| VPPRVIIKEGDVDVS | 156 | Q9NYV6 | |
| QGSEEEPSPVLKTLE | 486 | Q9HCH5 | |
| ESTPVALGAVTKAPV | 36 | Q92750 | |
| ELPKIVVVQSPDGSD | 446 | Q2M3C7 | |
| VSPDGTVTEAPRTVK | 106 | Q96HN2 | |
| QGPVVTEEIATSIEP | 536 | Q6UWJ1 | |
| RGTTPVSKPLEDIEA | 1241 | O95425 | |
| PPTAKGVVTIEQIVD | 576 | P09917 | |
| SDDEGTVFVPLTVIP | 106 | Q16609 | |
| GPKVVSKEIPVESIE | 251 | O60502 | |
| EPEVGKRPEETTVSV | 386 | P27987 | |
| TIKEKETPTPGEDIQ | 1651 | Q8NFP9 | |
| SVEDPPQRTAGVKVE | 226 | P38117 | |
| KTPEVVQSTRPIIEG | 1366 | O75376 | |
| VTPSRDKEPVFEVTG | 361 | Q5U5Q3 | |
| VEEVRIAASPKSTGP | 391 | Q86YN6 | |
| PEEGVTVESQPQVKV | 301 | O15446 | |
| ETPVGEETKTEAPES | 551 | Q9C0A6 | |
| TVANPVEGELPITVS | 371 | Q8NEZ3 | |
| VEGELPITVSVDVEP | 376 | Q8NEZ3 | |
| ESTGVLPPDVLVSEA | 311 | O15160 | |
| CDVVDEGVTKTPSTP | 541 | Q9UHV7 | |
| GTIPQPVARVVSEEK | 91 | Q6IE81 | |
| VVTVGDELEAPEPIT | 366 | O15079 | |
| SPVLTLTKVEGEERP | 16 | Q8IY50 | |
| APKETPVSGEVLETL | 1311 | Q7RTU9 | |
| IEVSIPGAEAPESSK | 781 | Q8N0Z3 | |
| ETVTERKATEPPQGL | 941 | Q09428 | |
| VVLEEDVIPLSPSVG | 136 | Q9NQ32 | |
| GSVVPTVQEPKDVLE | 436 | Q96JJ7 | |
| KPSEIEVGVVTVENP | 211 | P60900 | |
| EILESEVTGRAPKPT | 3331 | Q63HN8 | |
| VPLTVGKPEDTTEIS | 86 | Q8WWB5 | |
| GSVISPTELEAPILV | 351 | Q8N1B4 | |
| PSVATPGQVKELVEA | 271 | Q9UBS8 | |
| PGTVTVVKQVTEEEP | 1156 | Q9P243 | |
| TSQKIPEIPADVVGA | 1111 | Q12768 | |
| TEKIAPTTELVPKGE | 1706 | Q96RL7 | |
| PLVTEEKTVEPATVS | 1666 | Q96T58 | |
| LEEGPPVTTVLTRED | 46 | P08559 | |
| DTPLPDTEKTELTGV | 2331 | O60673 | |
| IIGKDEPPTLESTVQ | 4306 | Q15413 | |
| PVSVVGVTAAEEETP | 2066 | P22105 | |
| IGVTAAEEETPSPTE | 2386 | P22105 | |
| IGVTAAEEETPSPTE | 2711 | P22105 | |
| VIGVTAAEEETPAPT | 2926 | P22105 | |
| PVSAVGVTAPKDEAE | 3031 | P22105 | |
| VIPGEAEDKVSSEPS | 96 | Q96J42 | |
| SEVSPPKDLVVTEVT | 621 | P24821 | |
| IVGSITTGIDPPKDI | 856 | Q92752 | |
| VPTIASPVELLEGTE | 141 | Q9BZZ2 | |
| DPSTDGSQIIPKVTE | 21 | Q86WI1 | |
| VPPRVIIKEGDVDVS | 156 | A6NIE6 | |
| EEVKEPPGTNTVILE | 46 | Q9BSF0 | |
| KVRVEVEQGETSVPP | 1426 | Q9BYW2 | |
| TPEPVKEEVTVPATS | 326 | P49750 | |
| EKGLSSVPEIAEVEP | 1016 | P11137 | |
| GTVTEPAIQSEPETV | 231 | Q9HCJ5 | |
| PPDVTTVAVEETIPS | 261 | Q92956 | |
| LAPKETPVSGEVLET | 1311 | A6NGW2 | |
| PSDPTSKQVEGIEIV | 236 | P52739 | |
| LGVGPVTTVSPAKDE | 236 | A6NGA9 | |
| VTTVSPAKDEGPRSE | 241 | A6NGA9 | |
| GLAVEVKVPTEPLST | 21 | Q96IQ7 | |
| GKEAKVINEETTPPV | 1196 | Q6ZQQ6 | |
| SPVGEIGEEKILPTS | 1556 | P18583 | |
| ADSISESVPVGPKVR | 781 | P45974 | |
| ESPGVPVAKVVRAVT | 86 | Q9H1B5 | |
| VTLVPGIPTGDEKTV | 1281 | Q14966 | |
| GVILVEPEVTSTPLE | 871 | Q9NR99 | |
| VSKVSETVQEELTPP | 896 | P52179 | |
| GKPSDTSEPVLVEAR | 896 | P54296 | |
| TSEPVLVEARPGTKE | 901 | P54296 | |
| VLVEPTVSLIKGPDS | 166 | Q9NQS3 |